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CHAPTER I 
 
INTRODUCTION 
 
Staphylococcus aureus  
Staphylococcus aureus is a Gram positive bacterium that was discovered in 1880 
when Sir Alexander Ogsten observed that injecting pus from infected patients into mice 
produced similar abscesses (49). S. aureus harmlessly colonizes the squamous 
epithelium of the anterior nares of approximately thirty percent of the human population 
(50). However, upon breakage of host protective barriers, S. aureus is capable of 
invading and colonizing almost every organ in the human body, causing a diverse array 
of serious infections. The most common invasive diseases caused by S. aureus include 
bacteremia, pneumonia, osteomyelitis, endocarditis, and septic shock (48, 50). S. 
aureus infections are an escalating problem in developed countries, as the incidence of 
drug-resistant strains is rapidly increasing. In fact, as of 2005 invasive methicillin-
resistant S. aureus (MRSA) infections were responsible for more deaths annually in the 
United States than AIDS (9, 48). Particularly alarming is the emergence of vancomycin-
resistant strains, which suggests that complete antibiotic resistance of this bacterium is 
inevitable.  
S. aureus is an extremely successful pathogen due to its arsenal of effectors 
capable of opposing the various assaults of the host immune system. The initial 
response of the innate immune system to infection includes phagocyte activation and 
mobilization, opsonization to promote phagocytocis, and direct killing by antimicrobial 
peptides and reactive oxygen species (27). Virulence factors produced by S. aureus 
allow the bacteria to evade these host responses. For example, formyl peptides 
synthesized by bacteria activate neutrophils. S. aureus counters this immune activation 
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by secreting the chemotaxis inhibitory protein of staphylococci (CHIPS), which binds to 
the neutrophil formyl peptide receptor to block chemotaxis. Secretion of the extracellular 
adherence protein (Eap) also interferes with neutrophil chemotaxis by preventing 
leukocyte adhesion and extravasation (27). S. aureus also has several mechanisms for 
evading opsonization. The first defense is a capsular polysaccharide that coats the 
bacterium and limits neutrophil access to cell-surface molecules. Secondly, cell wall-
anchored protein A binds the Fc region of antibodies, effectively covering the bacterium 
in antibodies arranged in an orientation that is incompatible with neutrophil Fc receptor 
recognition. Moreover, S. aureus is able to oppose the complement system by secreting 
the staphylococcal complement inhibitor (SCIN), which prevents complement deposition 
on the bacterial surface (83). The cell wall-anchored protein IsdH is also capable of 
binding a component of the complement system (C3) in a way that hinders opsonization 
(113).  
If the host is able to overcome these evasion tactics and engulf staphylococci, 
the bacteria are capable of surviving in phagosomes in a semi-dormant state referred to 
as small colony variants (114). Modifications of wall teichoic acids and lipoteichoic acids 
naturally reduce the affinity of phagosomal cationic peptides to the bacterial surface. 
Additionally, secreted proteins such as staphylokinase and aureolysin inactivate 
antimicrobial peptides in the phagosome (27). S. aureus combats the neutrophil 
oxidative burst through expression of superoxide dismutases (SODs) and the yellow 
carotenoid pigment staphyloxanthin, which scavenges free radicals (99). Moreover, S. 
aureus can directly kill host cells by secreting toxins that damage host membranes, 
leading to cell lysis.  
In addition to the innate immune defenses mentioned above, the host actively 
starves invading pathogens of essential nutrients, a strategy referred to as “nutritional 
immunity” (117). The most important nutrient in the battle between host and pathogen is 
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iron, which is required for the growth of most bacteria but is unavailable in the 
mammalian host (8). Just as S. aureus has developed methods for combating the host 
innate immune system, it has also developed sophisticated mechanisms for iron 
acquisition during infection.  
 
Iron and Infection 
“In the resolution of the contest between invader and host, iron may be the 
critical determinant” (117). 
During infection bacteria encounter an environment in which greater than 90% of 
iron is intracellular, and therefore inaccessible (21). Vertebrates go to great lengths to 
sequester serum iron within proteins, rendering this vital metal inaccessible to invading 
pathogens. During infection, production of the extracellular iron-binding proteins 
lactoferrin and transferrin is increased. The intracellular iron-binding protein ferritin is 
also increased to efficiently sequester intracellular iron. These infection-induced 
alterations in iron-binding protein levels are mediated by the short peptide hepcidin, the 
master regulator of iron metabolism (34).  
At the initiation of a microbial infection the host-derived cytokine interleukin-6 
signals hepatocytes to elevate production and secretion of hepcidin. Hepcidin reduces 
extracellular iron levels by suppressing the secretion of dietary iron into the blood and 
stimulating macrophages to retain iron from recycled hemoglobin (34). Additionally, the 
synthesis and secretion of lactoferrin from neutrophil secondary granules is increased in 
the acute phase of infection (45). The macrophage transferrin receptor is down-
regulated, limiting the amount of transferrin-iron incorporated into the cells (35). 
Simultaneously, production of ferritin is increased to bind intracellular iron stores. The 
combined effect of these alterations is to decrease available iron inside the cells in order 
to withhold iron from intracellular invaders. The efficiency of this iron-withholding system 
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is exemplified by the disorder known as “anemia of chronic infection”. Decreased iron 
availability causes a reduction in red blood cell production, leading to anemia after 
prolonged infection (45, 127). 
The importance of iron sequestration techniques for combating infection is 
evident by the increased susceptibility to infection of individuals with iron overload 
diseases. For example, iron overload in macrophages (such as in African siderosis) 
causes an increased risk of tuberculosis, a bacterial infection which flourishes in iron-
loaded alveolar macrophages (116). Additionally, the administration of iron sucrose to 
hemodialysis patients is known to lead to an accumulation of non-transferrin-bound iron 
in the serum, which enhances the growth of S. aureus and the risk of developing sepsis 
(4, 41). Furthermore, in a murine model of Vibrio vulnificus infection, injection of excess 
iron into the mice reduced the LD50 from 6,000,000 to a single bacterium (124). 
Pathogens have evolved diverse sophisticated mechanisms to capture iron from 
many host iron-binding proteins. The majority of non-heme iron within vertebrates is 
bound by ferritin, lactoferrin, or transferrin. Ferritin, the intracellular iron storage protein, 
is unlikely to be used as an iron source by extracellular bacteria such as S. aureus. In 
contrast, lactoferrin is found in many bodily fluids, including saliva, tears, and nasal 
secretions (8). However, rather than promoting growth by providing the bacterium with 
iron, lactoferrin exhibits a bacteriostatic effect on S. aureus in vitro. This growth inhibition 
is attributed to both its iron-chelating properties and serine protease activity (1, 15). 
Alternatively, transferrin-iron is found in the serum and is a viable iron source to 
extracellular pathogens. Iron acquisition from transferrin is mediated primarily by 
siderophores in S. aureus (56, 70). Siderophores are low molecular weight iron chelators 
that have an extraordinarily high affinity for iron. After removing iron from transferrin, the 
siderophore-iron complex is recognized by bacterial receptors and internalized.  
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The vast majority of iron in the human body (approximately 80%) is found as a 
component of heme (21). Heme, or iron-protoporphyrin IX, is an essential cofactor in 
many proteins due to its robust redox potential. However, its reactivity also makes it a 
potentially dangerous molecule, as it catalyzes peroxidase and oxidase reactions which 
can result in damage to proteins and DNA. Vertebrates therefore sequester heme in 
hemoproteins to prevent oxidative damage. Hemoglobin, the major oxygen transport 
protein contained within erythrocytes, is the most abundant hemoprotein in mammals 
(19). Hemoglobin that is released into the serum upon erythrocyte lysis is quickly bound 
by circulating haptoglobin, which then traffics to the liver for degradation. In addition to 
hemoglobin, heme-iron is also bound by myoglobin, the oxygen storage protein in 
vertebrates. In vitro, S. aureus preferentially imports heme-iron when other iron sources 
are concurrently available, indicating that heme is most likely the primary source of iron 
during infection (97). S. aureus is able to utilize myoglobin as a heme-iron source in 
vitro; however, the mechanism by which this occurs and its relevance to pathogenesis 
are unknown (108).  
To acquire heme-iron from hemoglobin, S. aureus must first liberate hemoglobin 
from within host erythrocytes. To this end, S. aureus secretes several hemolysins which 
form pores in host cell membranes, causing lysis and release of cellular contents (60). 
Upon erythrocyte lysis, S. aureus binds the liberated hemoglobin and hemoglobin-
haptoglobin complexes via proteins of the iron-regulated surface determinant (Isd) 
system (98). The Isd system is comprised of nine iron-regulated proteins (IsdA-I) that act 
in concert to bind host hemoproteins, transport heme into the bacterial cytoplasm, and 
degrade heme to release nutrient iron (Figure 1). To date, the Isd system is the most 
extensively characterized heme-uptake system in Gram positive bacteria and 
homologues have been found in Bacillus anthracis, Listeria monocytogenes, and 
Clostridium tetani  (98). 
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Figure 1. Model of Isd heme acquisition in S. aureus. The model for heme transport 
predicts that once heme is removed from hemoglobin by IsdB or IsdH it is transferred in 
the following order: IsdA → IsdC → IsdE → IsdDF →IsdGI. PDB codes are as follows: 
IsdHN1 (2H3K), IsdHN3-heme complex (2Z6F), IsdA NEAT domain complexed with heme 
(2ITF), IsdC-heme complex (2O6P), IsdE-heme complex (2Q8Q), IsdG-N7A complexed 
with heme (2ZDO), IsdI complexed with cobalt protoporphyrin IX (2ZDP). Protein 
domains in gray are based on sequence similarity to proteins with a published structure. 
IsdHN1 shares 59% sequence identity with IsdHN2 and 46% sequence identity with 
IsdBN1. IsdHN3 shares 56% sequence identity with IsdBN2. IsdD and IsdF belong to the 
vitamin B12 ABC transporter family, the prototype of which is BtuCD from Escherichia 
coli (2QI9). 
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The iron-regulated surface determinant (Isd) system of S. aureus 
 The first obstacle in heme-iron acquisition during staphylococcal infection is the 
capture of host hemoproteins and the removal of heme. To this end, the hemoprotein 
receptors IsdB and IsdH (also called HarA) bind hemoglobin and hemoglobin-
haptoglobin complexes (22, 59, 73, 128). IsdH is the only staphylococcal haptoglobin-
binding protein, while both IsdB and IsdH exhibit hemoglobin binding activities. Although 
IsdH is capable of binding hemoglobin in vitro, inactivation of isdH does not alter the 
ability of S. aureus to utilize hemoglobin as an iron source. However, isdB mutants are 
impaired in their ability to use hemoglobin as a sole iron source, indicating that in S. 
aureus IsdB is the primary hemoglobin receptor (108). After binding the hemoprotein, the 
heme cofactor is removed via an as-yet undefined mechanism.  
Heme acquired from host hemoproteins must next be transported across the 
thick Gram positive cell wall, a process mediated by IsdA and IsdC (Figure 1). These 
cell-wall anchored proteins bind heme with modest affinity and traffic it across the dense 
layers of peptidoglycan (94, 112). IsdA is one of the most abundant proteins expressed 
on the surface of iron-starved S. aureus and it has been shown to bind a diverse array of 
host ligands. In addition to heme, IsdA has been reported to bind lactoferrin and the 
extracellular matrix proteins fibrinogen and fibronectin (15, 16). The biological 
ramifications of this broad binding specificity have not been established, but presumably 
IsdA-mediated ligand binding promotes the ability of S. aureus to adapt to its 
environment and colonize its host. IsdC is believed to function as the central heme 
channel from the outer cell wall to the cytoplasmic membrane due to its unique sortase 
B-catalyzed anchoring that positions it within the cell wall rather than exposed to the 
surface (57). 
From IsdC heme is transferred to IsdE, the lipoprotein component of the ATP-
binding cassette (ABC) transporter (38, 65). IsdD and IsdF are putative ABC transporter 
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components, in which IsdD is a membrane-associated ATP-binding protein and IsdF is a 
membrane-spanning permease (59). It is thought that the IsdE-heme complex will 
transfer heme through IsdF into the cytoplasm using energy generated by IsdD (81). 
 Once heme enters the cytoplasm, we propose that S. aureus can utilize heme in 
one of two ways: as a nutrient iron source or as a cofactor for bacterial hemoproteins 
(81). As well as being a valuable source of nutrient iron, heme is potentially useful to S. 
aureus in its intact form. Intact heme is required as a cofactor in numerous enzymes, 
many of which are found in the cytoplasmic membrane, such as cytochromes (106). It is 
possible that when iron is not a limiting nutrient, S. aureus will acquire low levels of 
heme for use in bacterial hemoproteins, as scavenging heme requires less energy than 
synthesizing heme de novo (72). This “molecular hijacking” hypothesis is supported by 
evidence that exogenous heme is preferentially acquired and segregated intact to the 
membrane when non-heme iron sources are concurrently available (97). More research 
is necessary to elucidate the fate of exogenously acquired intact heme and its role in 
bacterial hemoproteins (Chapter V).  
In order to utilize heme as an iron source the porphyrin ring must be cleaved to 
release the coordinated iron atom. Heme oxygenases are a ubiquitous family of 
enzymes that catabolize heme to carbon monoxide, α-biliverdin, and free iron (Figure 2). 
The Isd system includes two heme oxygenases dedicated to this task, IsdG and IsdI 
(96).  
 
Heme oxygenases 
The first bacterial heme oxygenase described was HmuO from Corynebacterium 
diphtheriae, which was identified based on its homology to human heme oxygenase 1 
(HO-1) (87). Since that initial report, numerous additional HO-1-like enzymes have been 
identified in bacteria (Table 1). Despite sharing little sequence identity, members of the 
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HO-1 family exhibit significant structural similarity. The HO-1 enzymes are monomeric α-
helical proteins, each with a single active site and GXXXG catalytic motif (Figure 2A) 
(90). Heme catabolism by the HO-1 family of enzymes has been studied extensively in 
both bacteria and vertebrates and the mechanism of heme degradation is believed to 
proceed similarly across most heme oxygenases (109). The canonical heme 
degradation reaction proceeds through a ferric hydroperoxo intermediate which self-
hydroxylates exclusively at the α-meso carbon of the porphyrin ring, ultimately resulting 
in the formation of α-biliverdin with concomitant release of carbon monoxide (CO) and 
free iron (Figure 2B) (111). In mammals biliverdin is further reduced to bilirubin by 
biliverdin reductase; however, the ultimate fate of biliverdin in bacteria is unknown as 
homologues of biliverdin reductase have not been discovered in bacteria. 
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Figure 2. Heme oxygenases of the HO-1 family degrade heme to α-biliverdin. A. 
Human HO-1 bound to heme (left panel, PDB 1N45) is compared to IsdG N7A mutant 
bound to heme (right panel, PDB 2DZO). The two monomers of IsdG are colored in 
different shades of purple. B. The canonical heme degradation pathway requires seven 
electrons and three moles of oxygen. Heme degradation results in carbon monoxide 
(CO), free iron, and α-biliverdin.  Abbreviations are as follows: Me, methyl (-CH3);  V,  
vinyl (-CH2-CH3); Pr, propionate (-CH2-CH2-COOH). The heme meso-carbons are 
labeled α, β γ, δ. 
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In addition to its role in heme catabolism, human HO-1 is essential for protecting 
against oxidative damage incurred during inflammation by generating antioxidants (14, 
47). In 1987, bilirubin, the end product of mammalian heme degradation, was found to 
be one of the most powerful serum antioxidants due to its extended system of 
conjugated double bonds and reactive hydrogen atoms (101). Heme degradation also 
produces equimolar concentrations of CO, a molecule with diverse functions in vivo. In 
humans >85% of endogenous CO results from heme catabolism. Although toxic at high 
concentrations, physiological levels of CO exert a multitude of beneficial effects, 
including vasodilatory, anti-inflammatory, and immunomodulatory (47). Moreover, the 
free iron that is liberated during heme catabolism up-regulates ferritin, another powerful 
cellular antioxidant (47). In addition, the intermediate biliverdin has been attributed 
antiviral activities (63). Considering the essential functions of biliverdin, bilirubin, CO, 
and iron within vertebrate cells, it is likely that heme catabolites also have important 
physiological roles in bacteria.  
Although the vast majority of HO-1-family enzymes produce α-biliverdin, a few 
exceptions have been observed. One example is pa-HO (PigA) from Pseudomonas 
aeruginosa which differs in its regiospecificity, producing a mixture of β- and δ-biliverdin 
(79). In addition, the blood-sucking insect Rhodnius prolixus degrades heme to 
dicysteinly-γ-biliverdin (69). In this heme degradation pathway heme is first modified by 
addition of two cysteinylglycine dipeptides, followed by oxidative cleavage of the 
porphyrin ring. The biological significance of these unconventional biliverdin molecules is 
not yet understood. 
The IsdG-family of heme oxygenases, first identified in S. aureus, is structurally 
distinct from the HO-1 family (Figure 2A). S. aureus expresses two paralagous heme 
oxygenases, IsdG and IsdI (96). Orthologues have been identified in other staphylococci 
and several pathogenic species of Bacillus and Listeria, as well as Mycobacterium 
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tuberculosis and the plant symbiont Bradyrhizobium japonicum (Table 1). IsdG-family 
members form homodimeric β-barrel structures with two separate active sites, each 
containing three residues (Asn, Trp, His) that are required for activity (125). Initial reports 
demonstrated IsdG-catalyzed cleavage of the macrocyclic ring with concomitant release 
of free iron, although the precise mechanism of heme degradation by this class of heme 
oxygenases has not yet been delineated (96). We have observed that in vitro heme 
degradation catalyzed by recombinant IsdG results in the formation of a yellow reaction 
product distinct from the blue-green biliverdin chromophore. Taken together, these 
structural and biochemical observations suggest that members of the IsdG-family of 
heme oxygenases degrade heme by a unique mechanism, resulting in the formation of a 
product that is distinct from biliverdin. The purification and structural determination of the 
products of IsdG- and IsdI-catalyzed heme degradation is described in Chapter IV. 
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Table 1. Bacterial heme oxygenases 
 
Species Heme Oxygenase(s) Reference 
HO-1 family   
Corynebacterium diphtheriae HmuO (87) 
Pseudomonas aeruginosa PigA, BphO (79) 
Neisseria spp. HemO (131) 
IsdG family   
Bacillus anthracis IsdG (95) 
Bradyrhizobium japonicum HmuD, HmuQ (76) 
Listeria monocytogenes IsdG (96) 
Mycobacterium tuberculosis MhuD (13) 
Staphylococcus aureus IsdG, IsdI (96) 
Other*   
Campylobacter jejuni ChuZ (82) 
Escherichia coli 0157:H7 ChuS (104) 
Helicobacter pylori HugZ (39) 
Leptospira interrogans HemO (64) 
 
* The ChuS structure is unlike that of the HO-1 family or IsdG family. ChuZ, HugZ, and 
L. interrogans HemO have not yet been structurally characterized.  
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Research objectives and significance 
 Herein I elucidate the genetic regulation of isdG and isdI and assess the 
contribution of heme degradation to staphylococcal pathogenesis. I found that although 
IsdG and IsdI share 64% sequence identity, they are differentially regulated according to 
the microenvironment experienced by the bacterium (Chapter II). This may represent a 
strategy by which S. aureus fine-tunes the expression of heme oxygenase activity during 
infection, as I found that bacteria lacking isdG and/or isdI exhibit differential virulence 
defects (Chapter II). In addition, I have identified a post-transcriptional regulatory 
mechanism in which IsdG is specifically stabilized in the presence of the substrate 
heme. Studies into the mechanism of this heme-dependent stability have identified two 
residues that are absolutely required for IsdG degradation in the absence of heme 
(Chapter III). Current experiments are aimed at identifying the protease(s) responsible 
for IsdG degradation (Chapter VI). Finally, we have determined the structure of the IsdG- 
and IsdI-catalyzed heme degradation products and shown that this new family of heme 
oxygenases degrade heme to a novel chromophore which we have named staphylobilin 
(Chapter IV).  
Collectively, my studies have significantly advanced our understanding of heme 
catabolism in S. aureus, a process that I have shown is required for staphylococcal 
pathogenesis. Additionally, I have identified a regulatory mechanism in which two similar 
proteins are differentially degraded, a potentially useful system for investigating 
mechanisms of substrate recognition by staphylococcal intracellular proteases. 
Moreover, the unique structure and mechanism of the IsdG-family of heme oxygenases 
indicates that these enzymes may be viable therapeutic targets. Future studies will build 
upon these foundational discoveries to determine the intracellular fate and function of 
staphylobilin and determine the functional relevance of IsdG degradation in vivo. 
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CHAPTER II 
  
STAPHYLOCOCCUS AUREUS HEME OXYGENASES ARE DIFFERENTIALLY 
REGULATED BY IRON AND HEME   
 
Introduction 
 
Staphylococcus aureus is able to obtain iron from heme during infection via the 
iron-regulated surface determinant (Isd) system. The nine proteins of the Isd system 
work in concert to bind host hemoproteins, remove the heme cofactor, and passage 
heme into the cytoplasm (59, 81). Once heme enters the cytoplasm it has been 
proposed that IsdG and IsdI, two paralogous heme oxygenases, degrade heme to 
release free iron for use as a nutrient source (98). In support of this model, IsdG and IsdI 
have been shown to catalytically degrade heme in vitro in a reaction that requires 
oxygen (53, 96). Further, S. aureus isdI expressed in trans is able to complement the 
heme utilization defect of a Corynebacterium ulcerans heme oxygenase mutant, 
indicating a role for IsdI in heme-iron utilization in vivo (96).  
In accordance with their role in iron acquisition, the cell wall-anchored and 
membrane transport proteins of the Isd system are regulated by the ferric uptake 
regulator (Fur), such that maximal expression occurs in iron-deplete environments (59). 
Fur is a ubiquitous bacterial transcription factor that binds consensus DNA sequences 
and inhibits transcription when iron is abundant (25). Many genes encoding bacterial 
heme oxygenases are also regulated in an iron-dependent manner, including: hmuO in 
Corynebacterium diphtheriae, hugZ in Helicobacter pylori, chuZ in Campylobacter jejuni, 
pigA in Pseudomonas aeruginosa, and hemO in Neisseria spp. (39, 67, 82, 85, 93). In 
addition to iron, hmuO is regulated by heme via two signal transduction systems. 
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Maximal hmuO promoter activity is observed in iron-deplete environments that contain 
heme or hemoglobin (5) 
Despite the accumulating data supporting a role for IsdG and IsdI in heme 
degradation during infection, the importance of IsdG and IsdI to staphylococcal biology is 
not yet known. Furthermore, regulatory networks governing the expression of these 
enzymes have not been explored. Additionally, a mechanistic explanation for why S. 
aureus encodes two paralogous enzymes that appear to be functionally redundant has 
not been provided. Finally, the contribution of heme degradation to pathogenesis has not 
been evaluated. This latter point is surprising in light of the fact that heme degrading 
enzymes have been described in twelve distinct genera of pathogenic bacteria (Table 1).  
 I sought to address each of these missing links by defining the role of heme 
oxygenases in staphylococcal biology and pathogenesis. Specifically, I demonstrate that 
IsdG and IsdI are each required for S. aureus heme utilization, as both are required for 
optimal growth on heme as a sole iron source. Investigation into the regulation of these 
enzymes reveals that IsdG and IsdI are differentially regulated by local iron and heme 
environments, providing a functional distinction between these two paralogous enzymes. 
Specifically, isdG and isdI are both transcriptionally regulated by iron in a Fur-dependent 
manner, while IsdG is also regulated post-transcriptionally by heme. Moreover, in vivo 
bioluminescence imaging indicates that isdI is expressed in infected tissues, primarily at 
the sites of abscess formation. Finally, I demonstrate that IsdG and IsdI are each 
required for full S. aureus virulence. Taken together, these results establish a role for 
heme degradation in bacterial pathogenesis and identify a complex regulatory system 
responsible for ensuring efficient heme catabolism during infection.  
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Methods 
 
Bacterial strains and growth conditions.  S. aureus clinical isolate Newman was used in 
all experiments (24). Isogenic variants lacking fur, isdC, isdD, isdE, isdF, srtB, isdG  
have been previously described (59). Mutations in isdI were made by allelic replacement 
of the coding sequence with tetM (3). The double heme oxygenase knockout strain 
(ΔisdGI) was made by transducing the ΔisdI::tetM allele into ΔisdG using the transducing 
phage Φ-85 as has been described previously (96). Bacteria were grown overnight (for 
stationary phase cultures) in tryptic soy broth (TSB) at 37°C with shaking at 180 rpm 
unless otherwise stated. 
 For complementation studies, S. aureus strains Newman ΔisdG and ΔisdGI were 
transformed with a plasmid encoding a full length copy of isdG under control of the S. 
aureus lipoprotein diacylglycerol transferase (lgt) constitutive promoter in the pOS1-
derived vector (7, 88). isdG coding sequence was PCR amplified from Newman genomic 
DNA and cloned into pCR2.1 (Invitrogen). Successful transformants were screened and 
those with the correct insert were subcloned into pOS1plgt, making pisdG. 
Heme nutrition plate assay. S. aureus strains Newman wild type, ΔisdG, ΔisdI, and 
ΔisdGI were passaged for 2 days in iron-deplete media (TSB + 1 mM 2,2’-dipyridyl [dip]) 
followed by a 4 hour subculture (1:100) in iron-deplete media. The cultures were then 
normalized by optical density and sedimented. The pellets were resuspended in TSB + 6 
mM dip and 60 µL was spotted in triplicate on TSA plates containing 6 mM dip and 
various concentrations of heme (Sigma). The iron-deplete, heme-containing plates were 
incubated at 37°C in the dark for 2-3 days and the diameter of each colony was 
measured using the AlphaImager (Alpha Innotech) software.  
Fractionation of staphylococci. Overnight cultures of S. aureus were normalized by 
optical density and sedimented. The bacteria were washed with Tris-buffered saline 
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(TBS, 50 mM Tris pH 7.5, 150 mM NaCl), resuspended in TSM buffer (100 mM Tris pH 
7.0, 500 mM sucrose, 10 mM MgCl2) and incubated in the presence of 30 µg lysostaphin 
at 37°C for 30 minutes. The samples were then pelleted and the supernatants (cell wall 
fraction) were collected and analyzed by 12% SDS-PAGE followed by immunoblotting. 
For analysis of membrane and cytoplasmic proteins, the protoplasts were resuspended 
in BugBuster Protein Extraction Reagent (Novagen) with proteinase inhibitor and 
sonicated for 10 seconds. The whole protoplast fractions were normalized by total 
protein concentration, separated by 15% SDS-PAGE, and analyzed by immunoblotting.  
Immunoblot Protein Quantification. Immunoblotting was performed in quadruplicate as 
described above. The intensities of the protein bands were quantified using the Odyssey 
System software by LI-COR, Inc. and were normalized by the intensities of the cross-
reacting protein A bands. 
RNA Isolation.  Overnight cultures of wild type S. aureus were subcultured (1:100) in 
triplicate into TSB alone, TSB supplemented with dip (1 mM), or TSB supplemented with 
dip and heme (5 µM). Mid-log phase cultures (OD600 = 0.25) were mixed with an equal 
volume of ice-cold ethanol-acetone and stored at -80°C. For RNA isolation, samples 
were thawed on ice and pelleted. Pellets were resuspended in RLT buffer and 
transferred to Lysing Matrix B tubes (MP Bio). Cells were lysed by processing in a 
FastPrep Instrument (MP Bio) two times for 20 sec each, followed by centrifugation. The 
supernatant was used for RNA isolation using RNeasy Mini kit according to 
manufacturer’s recommendations (QIAGEN). Contaminating DNA was removed by 
adding 10 units DNase I (Amersham Biosciences) to RNA samples and incubating in 
RQ1 buffer (Promega) at 37°C for 30 min. Following DNase treatment the samples were 
re-purified using the RNeasy Mini kit according to manufacturer’s protocol for RNA 
clean-up (QIAGEN). RNA concentration and purity were measured by optical density at 
260 nm and 280 nm, respectively. 
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Real time RT-PCR. For cDNA synthesis, 2 µg total cellular RNA was reverse transcribed 
with M-MLV reverse transcriptase according to manufacturer’s recommendations 
(Promega). 10 ng cDNA was amplified using Platinum Quantitative PCR SuperMix-UDG 
and SYBR Green I Nucleic Acid Stain (Invitrogen) in an iCycler iQ (Bio-Rad). The 
quantification of each sample was carried out relative to 16S rRNA and each PCR 
reaction was measured in quadruplicate. Relative quantification was performed using the 
comparative CT method according to User Bulletin #2: ABI Prism 7700 Sequence 
Detection System, Applied Biosystems, 2001. 
Pulse-Chase and Immunoprecipitation. Mid-log cultures of S. aureus ΔisdG pisdG grown 
in iron-deplete medium or iron-deplete medium supplemented with 10 µM heme were 
pelleted and washed three times in Dulbecco’s Modified Eagle’s Medium (DMEM) 
lacking methionine (Cellgro). Bacteria were then resuspended in DMEM lacking 
methionine and supplemented with iron sulfate (10 µM) or dip (1 mM), with or without 
heme (10 µM). Cells were then pulsed with 35S-methionine (110 µCi) for two minutes at 
37°C. Time zero samples were taken and added to an equal volume of 10% 
trichloroacetic acid (TCA) on ice. Subsequently, the chase solution (casamino acids, 
methionine, and cysteine) was added and samples were taken at the indicated time 
points and mixed with an equal volume of TCA on ice. Bacteria were then pelleted and 
washed with acetone. To remove the cell wall, bacteria were treated with lysostaphin (40 
µg) in TSM buffer for 30 minutes at 37°C and then pelleted and washed with acetone. 
Protoplasts were lysed by boiling in 0.5 M Tris, pH 7.5, 4% SDS. After pelleting, 
supernatants were removed and mixed with IsdG antisera diluted 1:500 in RIPA buffer 
for 1.5 hours. Subsequently 50 µL of protein A-sepharose slurry was added and 
incubated for 1 hour. Protein A beads were then washed and the bound antibody-protein 
complexes were removed by boiling in reducing SDS-PAGE sample buffer. Samples 
were separated by electrophoresis, dried, and analyzed using a PhosphorImager.   
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Murine model of infection.  Six to eight week old BALB/c mice (Jackson Laboratories) 
were infected with 4 x 106 colony forming units (CFU) of wild-type S. aureus Newman, 
ΔisdG, ΔisdI, or ΔisdGI mutant strains suspended in PBS by retroorbital injection. Four 
days post-infection mice were euthanized with CO2 and hearts and kidneys were 
removed and homogenized in sterile PBS. Colonization of each organ was determined 
by enumerating CFU on tryptic soy agar.  
Bioluminescence imaging.  The promoterless vector pXen coding for the luxABCDE 
operon of Photorhabdus luminescens, and modified for Gram positive bacteria, was 
obtained from Xenogen (28). The promoter region of DNA for isdI was cloned into pXen 
to make pisdI.Xen. The promoterless vector was used as a control for background 
luminescence in all experiments. Luminescence in vitro and in vivo was measured using 
the Xenogen IVIS 200 and LiveImage 2.0 software.  
 For in vivo bioluminescence imaging, six to eight week old BALB/c mice (Jackson 
Laboratories) were infected with 3 x 107 CFU of wild type Newman carrying either pXen 
or  pisdI.Xen suspended in PBS by retroorbital injection. Beginning 24 hours prior to 
infection, and continuing throughout the infection, mice were given chloramphenicol (0.5 
mg/mL) in their drinking water in order to select for bacteria carrying the plasmid. Four 
days post-infection the mice were euthanized with CO2 and organs were removed and 
imaged ex vivo. After imaging, the organs were homogenized in PBS and colonization 
was determined by enumerating colony forming units on tryptic soy agar in order to 
ensure the bacterial load in each organ was consistent between strains. 
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Results 
 
S. aureus IsdG and IsdI are required for growth on heme as a sole iron source.   
 IsdG and IsdI have been shown to catalytically degrade heme in vitro (96), 
however their contribution to staphylococcal heme-iron utilization has not been 
evaluated. To assess the role of IsdG and IsdI in vivo, we inactivated isdG and isdI, 
individually and in combination, in S. aureus strain Newman. We hypothesized that 
mutants lacking IsdG and/or IsdI would not be able to grow when heme is the only 
available iron source. Due to the lack of sensitivity of liquid growth assays, we sought to 
test our hypothesis by comparing the growth of S. aureus wild type, ΔisdG, ΔisdI, and 
ΔisdGI strains on solid media in which heme is the sole iron source. We observed that S. 
aureus lacking isdG, isdI or isdGI exhibit significantly impaired growth on heme as a sole 
iron source when compared to wild type (Figure 3). In contrast, all four strains show 
similar growth kinetics when grown on iron-rich or iron-depleted medium (data not 
shown). Interestingly, inactivation of isdG and isdI in combination does not enhance the 
heme utilization defect over that of either individual mutant strain. It is possible that this 
observation may be the result of the heme utilization defect reaching the limit of 
detection of the assay. Alternatively, this may be due to each enzyme having distinct 
functions in S. aureus. Importantly, the observation that both enzymes are required for 
efficient heme utilization strongly suggests that IsdG and IsdI have distinct contributions 
to heme catabolism. 
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Figure 3.  Growth of S. aureus heme oxygenase mutants on heme as a sole iron 
source. A. The colony diameter of S. aureus wild type ΔisdG, ΔisdI, and ΔisdGI was 
measured after growth on solid media containing an iron chelator and various 
concentrations of heme. B and C. Strains listed in A were transformed with an empty 
vector (pOS1) or a vector expressing isdG or isdI from a constitutive promoter (pisdG, 
pisdI) and colony diameter was measured as in A. Asterisks denote statistical 
significance between wild type and mutant strains (panel A) or mutant strains and 
complemented strains (panel B and C), as measured by Student’s t test (p < 0.0001). 
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To ensure that the absence of isdG and isdI is responsible for the observed 
defect in heme utilization, I performed complementation analyses. To this end, I provided 
a full-length copy of either isdG or isdI in trans in an effort to reverse the observed 
growth defects of the various mutant strains. I found that constitutive expression of isdG 
or isdI restores the growth of ΔisdG and ΔisdI respectively, confirming that the observed 
heme utilization defect of the mutants is due to the absence of heme oxygenase (Figure 
3B and C). Surprisingly, over-expression of either isdG or isdI restores the growth of the 
double mutant to wild-type levels when heme is the sole iron source (Figure 3B and C), 
indicating that over-expression of IsdG or IsdI is able to compensate for the lack of both 
heme oxygenases. These results suggest that S. aureus may encode for two heme-
degrading enzymes as a mechanism to fine-tune the abundance of heme oxygenase in 
the cell. 
 
IsdG and IsdI are differentially regulated by iron and heme.  
 IsdG and IsdI are not functionally redundant given that deletion of either isdG or 
isdI individually decreases the ability of S. aureus to grow on heme as a sole iron 
source. Moreover, over-expression of either IsdG or IsdI complements the loss of both 
enzymes, suggesting that the efficiency of heme utilization is impacted by the 
abundance of IsdG and IsdI. Based on these findings, we reasoned that isdG and isdI 
may be differentially regulated in S. aureus.  
Due to the location of putative Fur-binding sequences upstream of the 
transcription start sites for isdG and isdI (59, 96), we hypothesized that these enzymes 
are regulated by iron availability in a Fur-dependent manner. To test this hypothesis I 
employed immunoblotting to examine the expression of IsdG and IsdI following growth of 
S. aureus in media containing the iron chelator 2,2’-dipyridyl (dip). I observed an 
increase in the expression of both IsdG and IsdI as the concentration of iron chelator 
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was increased (Figure 4A). This iron-dependent increase was much more pronounced 
for IsdI as compared to IsdG. As a demonstration that this iron-dependent regulation of 
IsdG and IsdI is mediated by Fur, I found that a S. aureus strain inactivated for fur 
expresses IsdG and IsdI at levels comparable to those observed in maximally iron-
starved S. aureus (Figure 4A). These results demonstrate that IsdG and IsdI are 
regulated by iron in a Fur-dependent manner.  
As IsdG and IsdI are heme-degrading enzymes that are required for heme 
utilization (Figure 3), I next sought to investigate the effect of heme exposure on IsdG 
and IsdI expression. In an attempt to represent the predicted nutrient environment 
encountered during infection, I performed these experiments on iron-starved S. aureus. 
These experiments revealed that IsdI expression is not affected by exposing iron-starved 
S. aureus to heme (Figure 4B). In contrast, the abundance of IsdG is enhanced upon 
exposure to exogenous heme (Figure 4B). This heme-dependent increase in IsdG only 
occurs when S. aureus has been starved for iron, as IsdG was not detected when S. 
aureus was grown in iron-replete media supplemented with exogenous heme (data not 
shown). Although minor differences in absolute protein concentrations were observed 
between gels, the effect of heme and iron on IsdG and IsdI abundance was consistent 
across all experiments. 
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Figure 4. Regulation of IsdG and IsdI by iron and heme. The mean intensity of each 
band, as determined by densitometric analyses, is presented under the blots in arbitrary 
units, with corresponding standard error. Bands that were not detected for quantification 
are reported as not determined (n.d.). Statistical significance was determined using the 
Student's t test. Results are representative of at least four independent experiments. A. 
The effect of iron chelation by 2,2'-dipyridyl (dip) on expression of IsdG and IsdI was 
analyzed by immunoblot. Asterisks denote statistically significant increases, as 
compared with 0.01 mM dip (p < 0.0001). B. The effect of exogenous heme on 
expression of IsdG and IsdI in iron-deplete media (dip) was analyzed by immunoblot. 
Asterisks denote statistically significant increases, as compared with 0 µM heme 
(p < 0.03). The slight decrease in IsdI abundance in 10 µM heme compared with 0 µM 
heme is not statistically significant (p > 0.06). C. The effect of exogenous heme on 
expression of IsdG and IsdI in an isogenic Δfur strain was analyzed by immunoblot. 
Asterisks denote statistically significant increases, as compared with 0 µM heme 
(p < 0.0002). The slight decrease in IsdI abundance in 20 µM heme compared with 0 µM 
heme is not statistically significant (p > 0.1). 
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To determine if Fur contributes to the heme-dependent increase in IsdG 
expression, I monitored IsdG expression in S. aureus Δfur exposed to heme. In these 
experiments, a similar increase in the abundance of IsdG upon heme exposure was 
observed compared to wild type, indicating that Fur is not responsible for the heme-
dependent regulation of IsdG (Figure 4C). Taken together, these experiments show that 
IsdG and IsdI are differentially regulated by iron and heme. More specifically, IsdI is 
robustly expressed upon iron starvation whereas IsdG abundance is maximal in iron-
depleted medium containing heme.   
 
Proteins encoded within the Isd operon are differentially regulated by heme. 
 isdG is the terminal gene in the Isd operon (59, 96). In keeping with this genomic 
assignment, isdG is predicted to be co-transcribed with the upstream genes 
isdCDEFsrtB (Figure 5A). To test this, I analyzed the expression of IsdG in a S. aureus 
strain in which isdC has been inactivated by the insertion of an antimicrobial resistance 
cassette, which leads to transcriptional termination of the operon (ΔisdC) (59). 
Expression of IsdG in the ΔisdC mutant was abolished regardless of the growth 
conditions under study (data not shown), supporting the model that isdC and isdG are 
encoded within the same transcriptional unit. 
 Based on the assignment of isdG as the terminal gene in the Isd operon, we 
reasoned that all of the proteins encoded within this operon would be up-regulated when 
iron-starved S. aureus encounters heme. To test this, a series of strains inactivated for 
various components of the Isd operon were examined for protein expression in iron-
depleted media containing heme. As a negative control in these experiments, I analyzed 
the abundance of IsdI, as its expression is not affected by heme. As expected, IsdC, 
IsdD, IsdE, and SrtB were expressed in S. aureus Δfur. Surprisingly, IsdG is the only 
protein expressed from the isdCDEFsrtBisdG operon with enhanced expression in the 
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presence of heme (Figure 5B, wt dip+heme vs Δfur). Moreover, transcriptional 
termination at any gene upstream of isdG in the isdCDEFsrtBisdG operon abolishes 
expression of all downstream genes, further confirming that these genes are transcribed 
as a single unit. Taken together, these data suggest that the heme-dependent increase 
in IsdG expression occurs post-transcriptionally. 
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Figure 5. The role of transcription in the heme-dependent increase in IsdG. A. 
Schematic representation of the isd locus. The putative Fur-binding sites are denoted by 
black boxes upstream of putative transcription start sites (black arrows). orfX is an 
uncharacterized open reading frame upstream of isdI, and these genes are co-
transcribed. B. Immunoblot analysis of Isd proteins in S. aureus wild type grown in iron-
deplete medium containing heme (wt dip + heme) compared with isogenic strains lacking 
individual genes of the isd locus in identical growth media. All results are representative 
of at least three independent experiments. C. Transcript levels of isdC, isdD and isdG 
were analyzed by quantitative RT-PCR and normalized to 16S rRNA. S. aureus wild type 
was grown in iron-deplete media (dip, grey bars) and iron-deplete media containing 5 µM 
heme (dip + heme, black bars) and transcript levels were compared with those grown in 
TSB. Error bars represent the average range of triplicate experiments. 
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IsdG is regulated by heme via a post-transcriptional mechanism. 
 To investigate the mechanism responsible for the observed heme-dependent 
regulation of IsdG, I analyzed transcript levels of several isd genes in iron-rich medium, 
iron-deplete medium, and iron-deplete medium containing heme. I observed that 
transcript levels of isdC, isdD, and isdG are increased 40-70-fold upon iron starvation 
independent of heme, consistent with the Fur-regulation of this operon (Figure 5C). 
However, the transcript levels of isdC, isdD, or isdG from iron-starved S. aureus were 
not affected by heme exposure (Figure 5C). This is in stark contrast to the immunoblot 
analyses which showed an abundant increase of IsdG upon addition of heme to iron-
depleted medium (Figure 4). These experiments confirm that the heme-dependent up-
regulation of IsdG is occurring post-transcriptionally.    
 To determine if the post-transcriptional regulation of IsdG requires cis-acting 
sequences in the 5’ untranslated region of isdG, I analyzed the effect of heme on IsdG 
expression when isdG transcription is driven by a constitutive promoter. The ΔisdG 
pisdG strain was utilized for this assay, as the coding sequence of isdG is cloned directly 
downstream of the constitutive lgt promoter, which is not affected by heme (7, 100). This 
vector does not contain any of the sequences typically present in the genomic context 
surrounding isdG, and hence, expression can be monitored independently of potential 
regulatory sequences surrounding isdG. I observed a 2.3-fold increase in the abundance 
of IsdG when ΔisdG pisdG was grown on heme as the only iron source (data not shown, 
p < 0.015), indicating that the isdG coding sequence is sufficient for the heme-
dependent regulation of IsdG.  
 
IsdG protein stability is enhanced by heme.  
The heme-dependent increase in IsdG abundance in iron-deplete medium 
(Figure 4) is not a result of increased isdG transcription in this environment (Figure 5C). 
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One possible explanation for this is that the presence of heme stabilizes the IsdG 
protein. To investigate the iron- and heme-dependent stability of IsdG I utilized the S. 
aureus ΔisdG pisdG strain that constitutively expresses isdG. Following a pulse with 35S-
methionine, the fate of labeled IsdG was followed by immunoprecipitation over time. I 
observed that IsdG turnover is much more rapid in medium lacking heme as compared 
to medium containing heme, independently of the iron status (Figure 6A and C). In the 
presence of heme over 60% of the labeled protein remains after 150 minutes, whereas 
only 20% of the labeled protein remains at the end of the time course in the absence of 
heme. To determine if this heme-dependent stabilization is specific for IsdG, I performed 
a similar pulse–chase experiment to monitor the iron- and heme-dependent stability of 
IsdI. For these experiments, I utilized a S. aureus ΔisdI pisdI strain that constitutively 
expresses isdI. These experiments revealed that IsdI stability is unaffected by heme or 
iron status (Figure 6B and D). Combined with data from the qPCR results described 
previously, these data lead us to conclude that IsdG is most abundant when iron-starved 
in the presence of heme. This is an environment that is potentially encountered during 
infection following erythrocyte lysis.  
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Figure 6. The role of heme in the stability of IsdG and IsdI. A and B. 
Phosphorimages of radiolabelled IsdG and IsdI immunoprecipitated from cells pulsed 
with 35S-methionine, followed by a chase with unlabelled methionine for the time 
indicated. Pulse–chase analyses were carried out in media treated with iron sulfate 
(+Fe) or dip (−Fe) and 10 µM heme (+H). Dash indicates control cells in which primary 
antibody was omitted during immunoprecipitation. C and D. Quantification of IsdG and 
IsdI from quadruplicate experiments as described in A and B. Error bars represent 
standard deviation of data from at least three independent experiments. Asterisks 
denote statistical significance between conditions with and without heme irrespective of 
iron status, as measured by Student's t test (p < 0.003). 
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IsdG and IsdI are required for staphylococcal pathogenesis. 
I have shown that IsdG and IsdI are required for staphylococcal growth when 
heme is the sole iron source (Figure 3). An abundance of available heme in an otherwise 
iron-free host is an environment likely encountered during the course of infection. 
Additionally, it has been shown that hemoglobin binding and heme acquisition systems 
are required for staphylococcal pathogenesis (97, 108). Therefore, I sought to test the 
pathological relevance of heme catabolism by investigating the requirement for IsdG and 
IsdI in S. aureus pathogenesis. To determine the contribution of IsdG- and IsdI-mediated 
heme-iron utilization to staphylococcal virulence, a mouse model of systemic abscess 
formation was employed. Mice were infected intravenously with wild type, ΔisdG, ΔisdI, 
or ΔisdGI S. aureus. Enumeration of bacteria in organs removed from mice four days 
after infection revealed a decrease in bacterial load of up to 2 logs for each mutant strain 
as compared to wild type in the hearts of infected animals (Figure 7A and B). 
Additionally, infection with the ΔisdG and ΔisdGI strains resulted in a 1-log decrease in 
bacterial load compared to wild type in the kidneys (Figure 7C and D). Taken together, 
these results demonstrate the importance of IsdG- and IsdI- mediated heme catabolism 
in staphylococcal virulence. The virulence decrease of ΔisdG and ΔisdGI observed in 
the kidneys suggests that heme degradation by IsdG is more significant than that 
mediated by IsdI when S. aureus colonizes this organ. The reason for this organ-specific 
requirement for IsdG is not known at this time. Importantly, this is the first demonstration 
that bacterial heme degrading enzymes contribute to virulence. 
 33 
 
Figure 7. Contribution of IsdG and IsdI to S. aureus pathogenesis. S. aureus 
colonization of the hearts and kidneys of female Balb/c mice was analyzed 4 days post 
retroorbital infection. A and C. Colonization was compared between wild type, ΔisdG 
and ΔisdI strains. B and D. In a separate experiment, colonization of wild-type S. aureus 
was compared with the ΔisdGI strain. Each data point represents the CFU per organ in a 
single animal. The horizontal lines represent the mean CFU per organ. Asterisks denote 
statistical significance between wild type and the representative mutant strain as 
measured by Student's t test (p < 0.04).  E. S. aureus harboring pXen or pisdI.Xen was 
grown overnight in TSB or iron-deplete media (+dip). Serial dilutions were performed and 
luminescence was measured as described in the Methods. Luminescence scale is in 
p s−1 cm−2 srΔ−1. F. At 4 days post infection kidneys were removed and imaged ex vivo. 
Pictured are kidneys from mice infected with S. aureus carrying pXen or pisdI.Xen (left 
panels) and bioluminescent images of the same kidneys (right panels). Arrows indicate 
representative abscesses. Pictures and bioluminescent images are representative of at 
least five mice in each group. Bacterial load and number of abscesses were consistent 
between strains. 
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IsdI is expressed in tissue abscesses. 
 The decreased virulence of staphylococcal strains lacking isdG and isdI indicates 
that IsdG and IsdI are expressed and functional during infection. To investigate the 
expression of these enzymes in the context of infection I employed in vivo 
bioluminescence imaging (IVIS). This technique requires cloning the promoter of the 
gene of interest in front of the modified luciferase operon of Photorhabdus luminescens 
(28). When the promoter is activated the luciferase enzyme and its substrate are 
expressed and luminescence can be detected and quantified. The luminescent signal 
produced is of sufficient intensity to be detected through the tissues of an animal, thus 
enabling the detection of promoter activity in vivo. Because this technique monitors 
activation of a promoter, and our data indicate that IsdG is primarily regulated by a post-
transcriptional mechanism, we were not able to investigate the in vivo expression of 
IsdG using this technology.  
 I first grew wild type S. aureus carrying either the pXen vector (no promoter) or 
the pisdI.Xen vector in iron-rich medium or iron-deplete medium. As expected from the 
iron-dependent regulation of IsdI seen by protein analysis, the luminescent signal from 
bacteria harboring the pisdI.Xen vector is significantly increased in iron-deplete 
conditions (Figure 7E). Importantly, luminescence from the control vector is not above 
background levels from up to 108 bacteria, irrespective of the growth medium. To 
investigate the expression of IsdI in infected tissues, we infected Balb/c mice with wild 
type S. aureus harboring either pXen or pisdI.Xen, using the same infection protocol 
described above. Four days post-infection the organs were harvested and imaged ex 
vivo via the IVIS imaging system. Luminescence was detected in the kidneys and livers 
of mice infected with bacteria carrying the pisdI.Xen plasmid (Figure 7F and data not 
shown). Notably, the luminescence co-localizes with sites of abscess formation in both 
organs and this trend was reproducible in every mouse analyzed (n = 5). Although the 
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number of bacteria and abscesses were similar in the organs from mice infected with 
bacteria harboring the control vector, no luminescence was detected in any mouse 
infected with this strain (n = 6). These results indicate that IsdI is expressed in vivo 
during infection. Considering that the total number of CFUs in the kidneys does not 
typically exceed 107, the significant luminescence observed in each individual abscess 
strongly suggests that S. aureus is starved for iron inside tissue abscesses.  
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Discussion 
 
 S. aureus heme-iron acquisition is vital for pathogenesis, but the intracellular 
components of this process have yet to be fully described (97, 108). IsdG and IsdI, two 
cytoplasmic proteins of the Isd heme-uptake machinery, are capable of degrading 
exogenously acquired heme to release free iron in vitro (96). I have shown that IsdG- 
and IsdI-catalyzed heme degradation is biologically significant, as IsdG and IsdI are 
each required for S. aureus growth on heme as a sole iron source (Figure 3). 
Additionally, I have provided a mechanistic explanation for the presence of two similar 
enzymes, in that they are differentially regulated according to the environment 
encountered by the bacteria. I have also demonstrated the importance of IsdG and IsdI 
in staphylococcal pathogenesis, as strains lacking these enzymes exhibit decreased 
virulence (Figure 7 A-D). Moreover, I have shown that IsdI is expressed at the site of 
infection coincident with the location of abscess formation (Figure 7F). These in vivo 
data suggest that abscesses are iron-starved microenvironments. 
 Although heme oxygenases have been described in over ten genera of 
pathogenic bacteria, very little is known about the regulatory mechanisms controlling 
expression of these enzymes. The exception to this is HmuO of C. diphtheriae, which is 
maximally expressed in low-iron high-heme (or hemoglobin) (5). However, unlike IsdG, 
HmuO is regulated at the level of transcription by the combined activity of the diphtheria 
toxin repressor protein (DtxR) and the response regulators ChrA and HrrA (5). 
 The observation that IsdG and IsdI are differentially regulated provides insight 
into the basis for two paralogous enzymes in S. aureus with seemingly identical 
functions. IsdG and IsdI are both regulated at the transcriptional level by Fur in response 
to iron availability (Figure 4 and 5). Additionally, IsdG abundance is regulated by heme 
availability via a post-transcriptional mechanism controlling protein stability (Figure 6).  
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P. aeruginosa is the only other pathogenic bacteria known to encode for two heme 
oxygenases (PigA and BphO). These have been shown to differ in their catalytic 
regiospecificity, in that they each produce a distinct isomer of biliverdin upon heme 
degradation (115). Although the regiospecificity of IsdG- and IsdI-catalyzed heme 
degradation is not yet known, it appears that in the case of S. aureus, the significance of 
encoding for two paralogous heme oxygenases is to fine-tune the expression of these 
enzymes according to the microenvironment encountered by the bacteria. 
 S. aureus is able to colonize and infect virtually every tissue of the vertebrate 
host. This diverse ecological range invariably requires significant flexibility in nutrient 
acquisition systems.  It is tempting to speculate that, in the case of heme degradation, 
this flexibility is mediated by alterations in the abundance of IsdG and IsdI in response to 
heme and iron. The human body is virtually devoid of free iron due to the fact that the 
vast majority of iron is complexed as a component of heme (8). In healthy individuals, 
heme is bound to hemoglobin within erythrocytes and myoglobin within myocytes. 
During systemic infections, it is modeled that S. aureus can access this heme through 
the secretion of a number of potent hemolysins. Hemolysin expression is regulated in 
response to bacterial density by global virulence factors, which allow for controllable 
erythrocyte lysis at a time when colonization has been established and nutrient-iron 
needs are high (23, 44). In keeping with this model, it is possible that IsdI is expressed 
upon entry into the host to ensure that the low level of heme entering the staphylococcal 
cytoplasm is degraded and the iron is released. Following bacterial seeding of host 
organs, significant erythrocyte lysis is likely. Based on the efficiency of the Isd system for 
hemoglobin recognition and heme transport (59), this lysis would lead to a 
commensurate increase in heme transport into the staphylococcal cytoplasm. The 
intracellular amassing of heme would then stabilize IsdG, hence increasing its 
abundance. In effect, the simultaneous expression of both IsdG and IsdI would increase 
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the capacity of S. aureus to deal with a heme surplus. We predict that IsdG and IsdI 
abundance remains high until the nutrient iron needs of the organism have been 
satisfied. Considering that IsdI remains expressed inside abscesses four days following 
infection, it appears that S. aureus remains iron-starved during the course of infection in 
the animal model used in this work.  
In support of this model, Cheng et al. recently reported that isdA and isdB 
mutants are defective in kidney abscess formation. In a wild type infection abscesses 
develop 2 – 5 days following infection, reinforcing the supposition that Isd-mediated 
heme uptake is required after bacterial seeding of host organs. Scanning electron 
microscopy also revealed the presence of red blood cells, a potential heme source, 
within staphylococcal communities at the center of abscesses. Based on these data, 
they propose a model in which heme-iron scavenging is required during abscess 
formation and maturation (12). 
 The presence of heme delays or prevents IsdG degradation, increasing the 
stability of the protein by 2.5-fold (Figure 6), representing a significant change in 
abundance for a catabolic enzyme. This regulatory strategy may be mediated by 
enzyme stabilization upon substrate binding. In keeping with this, it is possible that IsdG 
undergoes a conformational change or is partially unfolded in the absence of heme and 
is therefore targeted by proteases for degradation. Alternatively, heme could be 
stabilizing IsdG by binding outside the active site in a manner that hides or distorts 
possible protease target sites. Heme regulatory motifs (HRMs) have been described in 
eukaryotes and prokaryotes and are involved in heme-dependent transcription, 
translation, protein translocation, and protein stability (61, 77). HRMs are short sequence 
motifs containing an invariant cys-pro sequence. When heme binds an HRM it induces a 
conformational change, altering the function of the protein (61). This type of mechanism 
is unlikely in the case of IsdG, due to the lack of any cysteine or proline residues. 
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Additionally, the recent co-crystal structure of heme-bound IsdG reveals heme bound 
only in the active site (53). However, it is formally possible that heme can bind elsewhere 
on the protein under in vivo conditions, resulting in enhanced stabilization of IsdG.  
 In the present study, I demonstrate the role of IsdG and IsdI in staphylococcal 
heme-iron utilization and pathogenesis. Additionally, I reveal the mode of regulation to 
be a functional difference between these paralogous enzymes. Interestingly, IsdG and 
IsdI are 78% similar at the amino acid level, but only IsdG is post-translationally 
regulated by heme. Further experiments are necessary to provide a mechanistic 
explanation for the heme-dependent IsdG stabilization (Chapter III). The finding that 
IsdG and IsdI are required for full staphylococcal virulence establishes these enzymes 
as viable targets for the generation of novel antimicrobials to treat S. aureus infections. 
The potential to design small molecule inhibitors that specifically target bacterial heme 
oxygenases is further supported by the significant structural differences between this 
class of enzymes and the human heme oxygenases (91, 125). Considering the 
conservation of this enzyme family across B. anthracis, L. monocytogenes, M. 
tuberculosis, and the pathogenic Staphylococci, antimicrobials targeting the IsdG-family 
of heme oxygenases have the potential to be broadly applicable across a variety of 
infectious diseases.  
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CHAPTER III 
  
ELUCIDATING THE MECHANISM OF IsdG DEGRADATION 
 
Introduction 
 
 During infection of a vertebrate host Staphylococcus aureus encounters an 
environment in which greater than 80% of iron is found as a component of heme, the 
majority of which is bound to hemoglobin (8). In order to acquire iron for use as a 
nutrient source, S. aureus elaborates the iron-regulated surface determinant (Isd) 
system which binds host hemoglobin, removes the heme cofactor, and transports heme 
into the cytoplasm (98). The cytoplasmic components of this system are IsdG and IsdI, 
two paralagous heme oxygenases that degrade heme to release nutrient iron (96). IsdG 
and IsdI are each required for growth on heme as a sole iron source, an environment 
which is predicted to mimic conditions experienced by the bacterium during infection. 
Accordingly, each are required for staphylococcal pathogenesis in a murine model of 
systemic infection (80). 
 IsdG and IsdI degrade heme similarly, are 64% identical at the amino acid level 
and the three-dimensional structures can be superimposed with a root mean square 
deviation of less than 2 Å (53, 96). However, the observation that strains lacking either 
heme oxygenase are impaired for growth on heme indicates that IsdG and IsdI are not 
functionally redundant enzymes. In fact, IsdG and IsdI are differentially regulated by iron 
and heme depending on the microenvironment encountered by the bacteria (80). Under 
low iron conditions Fur-mediated transcriptional repression is released and isdG and isdI 
are transcribed. IsdG is also regulated at the post-transcriptional level such that IsdG is 
degraded in the absence of heme. Therefore, IsdI is most abundant in low iron 
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conditions, while IsdG levels are maximal in iron-deplete environments containing heme 
(80). We hypothesize that this differential regulation allows the bacteria to fine-tune the 
expression of heme oxygenase activity in order to adapt to the specific environment it 
encounters. However, the mechanism by which IsdG is specifically stabilized by heme 
has not yet been uncovered.  
 Bacteria are constantly monitoring proteins as a quality control measure to 
ensure that misfolded or damaged proteins do not accumulate and cause toxicity. 
Degradation of specific proteins may also allow the bacterium to rapidly adapt to 
changing environments when the activity of those proteins is no longer required. Protein 
turnover is accomplished through molecular chaperones that bind misfolded and 
aggregated proteins, and proteases that degrade nonnative proteins that cannot be 
salvaged (119). Bacterial proteases consist of an ATPase component, which recognizes 
and unfolds substrates in an ATP-dependent manner, and a proteolytic component 
responsible for protein destruction. Several ATPase subunits have also been shown to 
have chaperone activity independent of their role in protein degradation (42).  
Protease substrate specificity is absolutely critical to prevent the uncontrolled 
degradation of normal cellular proteins. This fact is highlighted by the recent 
identification of a novel antibiotic that exerts its toxicity by binding an intracellular 
protease, rendering it constitutively active (6). The best characterized targeting 
mechanisms in bacteria are the N-end rule pathway and the SsrA tag. The N-end rule 
describes a universal system across Kingdoms in which the stability of a protein is 
dependent on its amino-terminal residue (2). The SsrA tag is an eleven amino acid 
peptide added to the carboxy-terminus of incomplete polypeptides upon ribosome 
stalling. Approximately 0.5% of E. coli proteins are SsrA-tagged during normal 
translation (66); however, the process of SsrA-tagging has not been investigated in S. 
aureus.  
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We sought to uncover the mechanism by which IsdG is specifically targeted for 
degradation in the absence of heme. The rate of IsdG degradation makes it an unlikely 
substrate for the N-end rule or the SsrA-tagging system, as both targeting mechanisms 
result in rapid degradation of substrates (54, 62, 80). Therefore, we hypothesized that 
IsdG is targeted for degradation by a novel mechanism. Here I show that IsdG catalytic 
activity is not required for heme-dependent IsdG stability. Furthermore, IsdG degradation 
is ATP-dependent, indicating that an ATP-dependent protease is responsible for IsdG 
degradation in the absence of heme. Finally, I demonstrate that the flexible loop region 
of IsdG, and specifically asparagine 84, is required for IsdG degradation. Combined, 
these results begin to elucidate the mechanism of heme-dependent IsdG stability. 
Moreover, these studies will lead to an increased understanding of targeted protein 
degradation in general, as the IsdG recognition sequence may be widely utilized in 
staphylococcal protein turnover.  
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Methods 
 
Bacterial strains and growth conditions.  S. aureus clinical isolate Newman was used in 
all experiments (24). The isogenic mutant lacking isdG has been described previously 
(80). Bacteria were grown in TSB at 37°C with shaking at 180 rpm unless otherwise 
stated.  
IsdG mutagenesis. PFU mutagenesis was utilized to create point mutations in 
pET15b.isdG (118). All mutants were confirmed by sequencing (Vanderbilt University 
DNA sequencing facility). Plasmids were then transformed into E. coli BL21(DE3) pREL 
for expression and purification, as described previously (96). Heme binding was 
measured spectrophotometrically, as described previously (96). IsdG mutant coding 
sequences were excised using NdeI and BamHI and were inserted into pOS1plgt (7). 
The pisdG mutant vectors were then transformed into the restriction negative strain 
RN4220, followed by transformation into Newman ΔisdG. The wild type pisdG 
complementation vector has been described previously (Chapter II). 
Pulse-chase and immunoprecipitation. Pulse-chase analyses were performed as 
described in Chapter II.  
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Results 
 
IsdG catalytic activity is dispensable for its heme-dependent stability. 
 In the presence of heme, IsdG degradation is markedly reduced (80). However, it 
is not known if IsdG is stabilized by heme or the product of heme degradation. To 
separate the catalytic activity and the heme-dependent stability of IsdG, I performed 
pulse-chase analyses on the IsdG N7A mutant, which binds heme but is not capable of 
degrading heme (53). It is expected that if the product of heme degradation is required 
for IsdG stability, the catalytically inactive N7A mutant will be degraded in both the 
presence and absence of heme. I observed a similar decrease in protein levels in the 
absence of heme for both the wild type and N7A mutant proteins (Figure 8). I 
hypothesize that the slight increase in IsdG N7A stability compared to wild type 
observed in the absence of heme is due to the irreversible binding of endogenous heme 
which stabilizes the inactive protein. Importantly, the stability of both proteins was 
increased similarly upon addition of heme (Figure 8). These results demonstrate that 
IsdG catalytic activity is dispensable for its stability. Therefore, the stability of IsdG is 
dependent upon the presence of substrate and not the product of heme degradation.  
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Figure 8. The role of heme degradation in IsdG stability. Pulse-chase analysis of S. 
aureus ΔisdG pisdG wild type and N7A point mutant which can bind heme but is 
catalytically inactive. A. Representative phosphorimages of immunoprecipitations over 
time in the presence and absence of heme. B. Percent IsdG remaining 150 minutes after 
addition of chase solution. Fe designates iron-replete samples lacking heme. Error bars 
represent the standard deviation of at least three independent experiments. 
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IsdG stability is increased by inhibiting ATPases. 
IsdG stability is increased in the presence of exogenously added heme. We 
hypothesize that in the absence of substrate IsdG is specifically targeted for degradation 
by intracellular proteases. ATP-dependent intracellular proteases in S. aureus include: 
ClpCP, ClpXP, HslUV, and FtsH. The ATPase components of the Clp proteolytic 
complexes, ClpC and ClpX, also have chaperone activities independent of their role in 
proteolysis. Additionally, ClpX has been shown to have ATP-independent activities in 
Bacillus subtilis (40). Furthermore, ATP-independent cellular peptidases may play a role 
in protein turnover, although they have not been well described in S. aureus (89). The 
factor(s) required for IsdG turnover in the absence of heme are currently unknown.  
To determine if IsdG degradation in the absence of heme is mediated by an ATP-
dependent protease, we first analyzed the stability of IsdG in the presence of the 
respiratory poison sodium arsenate. Sodium arsenate structurally mimics inorganic 
phosphate, thereby inhibiting all cellular ATPases. A significant increase in IsdG stability 
is observed upon addition of sodium arsenate to the medium, an effect which occurs 
independently of heme (Figure 9). These results demonstrate that IsdG degradation in 
the absence of heme requires ATP, supporting the hypothesis that IsdG is specifically 
degraded by an ATP-dependent protease. 
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Figure 9. The role of ATP in IsdG stability. Pulse-chase analysis of S. aureus ΔisdG 
pisdG in the presence and absence of the respiratory poison sodium arsenate. Inset is a 
representative phosphorimage. Error bars represent the standard error of at least three 
experiments. Asterisks represent a statistically significant difference as compared to no 
additive (* p < 0.03, ** p < 0.005). 
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The flexible loop is required for IsdG degradation. 
 IsdG stability is ATP-dependent and requires the presence of exogenous heme. 
Therefore, we hypothesize that in the absence of substrate IsdG is specifically degraded 
by staphylococcal proteases. To that end, I sought to identify the region of IsdG that is 
recognized and targeted for degradation. We focused our search on α-helices and 
regions without secondary structure based on a recent proteome-wide analysis of 
proteolysis which found that β-strands are rarely tolerated in the cleavage sites of 
proteases (107). Additionally, the heme-dependent nature of IsdG degradation allows us 
to narrow our search to regions that undergo a conformational change upon heme 
binding. The differential regulation of IsdI, a paralagous protein which is 64% identical to 
IsdG but is not degraded, allows us to restrict our analysis further to regions that are 
dissimilar between the two enzymes (80, 96).   
In silico analysis of IsdG and IsdI sequences indicated that amino acids 82-88 of 
IsdG comprise the region of highest divergence between the two proteins and is the 
most surface exposed region (Figure 10A). The apo-protein crystal structures reveal this 
region to be a disordered loop in both proteins that becomes ordered and more rigid 
upon porphyrin-binding (53, 125). Thus, amino acids 82-88 comprise the highest 
sequence divergence between IsdG and IsdI, is the region with the most drastic 
conformational change upon heme binding, and lacks secondary structure in the 
absence of heme. We hypothesized that this region may play a role in the difference in 
IsdG and IsdI stability. This hypothesis is supported by a recent report which concluded 
that the presence of a flexible loop is the critical component of an optimum protease 
cleavage site (107). 
 To test the role of the flexible loop in IsdG stability I constructed a chimeric IsdG 
protein that contains the IsdI loop amino acid sequence (IsdGloop*) and tested its stability 
by pulse-chase analysis (Figure 10A). IsdGloop* is significantly more stable than wild type 
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protein in the absence of heme (Figure 10B). More than 50% of the labeled IsdGloop* 
protein remains after 150 minutes in comparison to 20% of wild type. In fact, IsdGloop* is 
equally stable in the absence of heme as wild type IsdG in the presence of heme, 
indicating that IsdGloop* stability is heme-independent. The IsdGloop* mutant in the 
presence of heme shows a trend towards greater stability than wild type, however this 
difference is not significant (Figure 10B). These results demonstrate that the IsdI loop 
sequence confers heme-independent stability upon IsdG and suggests that this region of 
IsdG may be recognized for degradation in the absence of heme. 
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Figure 10. The role of the flexible loop in IsdG stability. A. Alignment of the flexible 
loop regions of IsdG and IsdI. IsdGloop* is an IsdG mutant with residues 82-88 mutated to 
the corresponding amino acid sequence of IsdI. The crystal structure of IsdI (blue) is 
superimposed with that of IsdG (gray) with heme depicted in a ball and stick model. The 
IsdG flexible loop is highlighted (magenta). B. Quantification of pulse-chase analyses of 
S. aureus ΔisdG pisdGloop*. Asterisks indicate statistically significant differences as 
compared to IsdG wild type in the same growth medium (* p < 0.03, ** p < 0.005).  
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In order to more precisely define the sequence of IsdG required for its targeted 
degradation, a series of single point mutations in the flexible loop of IsdG were 
constructed. IsdG S82L is more stable than wild type in the absence of heme 30, 60, 
and 120 minutes following addition of the chase solution (Figure 11A). However, 
similarly to wild type, only 20% of the labeled S82L mutant protein remains after 150 
minutes, suggesting that this mutation slows the degradation of IsdG, but does not inhibit 
degradation. IsdG N84S is significantly more stable than wild type in the absence of 
heme at all time points after 60 minutes (Figure 11B). Moreover, IsdG N84S stability is 
not significantly altered upon addition of heme, revealing that mutation of a single 
asparagine abolishes the heme-dependent stability of IsdG. Importantly, the difference in 
stability is not due to altered heme binding or degradation, as all IsdG mutants tested are 
able to bind and degrade heme similarly to wild type (data not shown).  
IsdG 87[GQ]88, in which the flexible loop is elongated by two amino acids, is not 
altered in overall stability (Figure 11C). This was unexpected given that longer flexible 
loops are favorable for protease-mediated degradation (107). Thus, it is possible that the 
flexible loop is the recognition sequence, but not the site of protease cleavage. 
Combined, these results demonstrate that asparagine 84 is the critical component of the 
flexible loop in the degradation of IsdG.  
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Figure 11. The stability of IsdG point mutants. A-C. Quantification of pulse-chase 
analyses of S. aureus ΔisdG pisdG loop mutants. D. Percent IsdG remaining 150 
minutes after addition of chase solution. Error bars represent the standard error of at 
least three independent experiments. Asterisks indicate statistically significant 
differences as compared to IsdG wild type in the same growth medium (* p < 0.03, ** p < 
0.005). 
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The flexible loop is not sufficient to target a protein for degradation.  
We next sought to determine if the sequence of the IsdG flexible loop is sufficient 
to target a protein for degradation. To test this an IsdI chimera which encodes for the 
loop sequence of IsdG (IsdIloop*) was constructed and analyzed for heme-dependent 
stability. I predicted that the IsdIloop* mutant would be degraded in the absence of heme. 
However, pulse-chase analyses showed that the IsdIloop* mutant protein stability is 
identical to that of wild type (data not shown). This result does not preclude the flexible 
loop being the target cleavage site or recognition sequence for IsdG. Proteases are not 
solely influenced by the amino acid sequence of the cleavage site. Rather, sequences 
surrounding the cleavage site are also known to play a role in the specificity of protease 
recognition. Additionally, secondary site interactions at surfaces distinct from the 
cleavage site may also be important for effective protease cleavage (107). Therefore, we 
conclude that the flexible loop is required for IsdG degradation in the absence of heme, 
although it is not a sufficient targeting sequence for proteolysis.  
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Discussion 
 
S. aureus expresses two paralagous heme oxygenases that are differentially 
regulated depending upon the environment encountered by the bacterium. isdG and isdI 
are both transcribed under iron-limiting conditions while IsdG is additionally regulated 
post-transcriptionally by heme (Chapter II). The mechanism of the heme-dependent 
regulation of IsdG has not yet been investigated. Here I show that the catalytic activity of 
IsdG is dispensable for IsdG stability. This result demonstrates that the product of heme 
degradation is not required for IsdG stability. Furthermore, IsdG degradation is ATP-
dependent, suggesting that an ATP-dependent protease degrades IsdG in the absence 
of heme. Finally, I establish that the flexible loop sequence, specifically asparagine 84, is 
required for IsdG degradation. Combined, these results begin to elucidate the 
mechanism of IsdG heme-dependent stability.  
In iron-deplete environments S. aureus elaborates the Isd system in order to 
obtain heme-iron during infection (98). This system includes cell wall-anchored 
hemoprotein receptors, membrane heme transport proteins, and the cytoplasmic heme 
oxygenases IsdG and IsdI. We predict that upon encountering an iron-deplete 
environment without heme S. aureus adapts by decreasing heme oxygenase activity in 
the cell. This is accomplished through the specific proteolysis of IsdG. A precedence for 
substrate-dependent stability comes from the quorum-sensing regulator TraR in 
Agrobacterium tumefaciens. TraR requires its signal molecule, an autoinducing peptide 
(AAI), for proper folding and stability (129). It is postulated that the hydrophobic core of 
TraR is exposed to solvent in the absence of AAI, resulting in aggregation and 
proteolysis. However, in this system TraR that is synthesized in the absence of substrate 
is rapidly degraded with a half-life of 2 minutes. IsdG has a longer half-life in the 
absence of substrate (~67 minutes), suggesting that IsdG is properly folded in the 
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absence of heme, but is targeted for degradation at a step after translation and protein 
folding.  
Post-translational regulation mediated by proteolysis must be a highly specific 
process to avoid degrading native proteins. Eukaryotes achieve specificity through a 
conserved tagging system that covalently attaches the small protein ubiquitin to lysine 
residues of the substrate. Enzymes that recognize ubiquitin-tagged proteins then present 
the substrate to the proteasome for degradation. An analogous system was recently 
identified in M. tuberculosis (71). The prokaryotic ubiquitin-like protein (Pup) is a small 
disordered protein that is covalently attached to the ε-amino groups of substrate lysines. 
The adaptor protein Mpa then unfolds the substrates and translocates them into the 
proteasome for degradation (11, 71). Although bacterial proteases such as ClpCP, 
ClpXP, and HslUV are structurally similar to the proteasome, a similar tagging system to 
ubiquitin and pupylation has not been identified in bacteria outside the Actinomycetes 
class (20). 
Substrate recognition by bacterial proteases is multifaceted and requires precise 
structural presentation, cleavage site sequence and subsite specificity, and appropriate 
secondary site interactions (107). A recent study of the structural features of proteolytic 
substrates found that loop size and target sequence play critical roles in defining the 
susceptibility of protein substrates (18, 107). In fact, eukaryotic ubiquitin-tagged proteins 
are stable in vitro unless they also contain an unstructured region (89). Herein I have 
shown that the flexible loop sequence is required for IsdG degradation, although it is not 
sufficient. These results indicate that other factors, which may include subsite sequence 
specificity and secondary site recognition, play a role in IsdG stability. Ongoing 
experiments are aimed at elucidating the mechanism of IsdG degradation, particularly to 
identify the minimal region that is sufficient to target a staphylococcal protein for 
degradation (Chapter VI).    
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IsdG and IsdI are each required for S. aureus growth on heme as a sole iron 
source, an environment likely encountered during infection of a vertebrate host. 
Accordingly, IsdG and IsdI are both required for staphylococcal pathogenesis. 
Furthermore, a S. aureus mutant lacking isdG is more attenuated for virulence than the 
isdI mutant in both the hearts and kidneys of infected animals (Chapter II). This 
observation suggests that the differential regulation of IsdG and IsdI may be critical 
during pathogenesis. Moreover, a novel class of antibiotics was recently identified that 
exerts toxicity through the binding and constitutive activation of bacterial proteases (6). 
Combined, these facts suggest that elucidating the mechanism of IsdG degradation may 
lead to the identification of novel therapeutic targets. As S. aureus is increasingly 
becoming resistant to all available antibacterial agents, identifying novel therapeutic 
targets to combat this important pathogen is critical.  
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CHAPTER IV 
 
THE IsdG-FAMILY OF HEME OXYGENASES DEGRADES HEME TO THE NOVEL 
CHROMOPHORE STAPHYLOBILIN 
 
Introduction 
 
During infection of a vertebrate host Staphylococcus aureus preferentially 
acquires iron from heme bound to host hemoglobin (97). In order to utilize heme as a 
nutrient iron source bacteria must cleave the tetrapyrrole ring to release the coordinated 
iron atom. This task is accomplished by heme oxygenases that catabolize heme to 
carbon monoxide, α-biliverdin, and free iron. The first bacterial heme oxygenase 
described was HmuO from Corynebacterium diphtheriae, which was identified based on 
its structural homology to human heme oxygenase 1 (HO-1) (86). Since that initial 
report, numerous additional HO-1-like heme oxygenases have been identified in both 
plant and mammalian pathogens (Table 1) (78, 122, 130). Extensive biochemical 
analyses of bacterial and vertebrate HO-1-like enzymes indicate that the mechanism of 
heme degradation is similar across all heme oxygenases, resulting in the production of 
biliverdin (110). In mammals biliverdin is further reduced to bilirubin by biliverdin 
reductase; however, the ultimate fate of biliverdin in bacteria is unknown as homologues 
of biliverdin reductase have not been discovered in bacteria. 
 The IsdG-family of heme oxygenases, first identified in S. aureus, is structurally 
distinct from the HO-1 family. Initial reports demonstrated IsdG-catalyzed cleavage of 
the macrocyclic ring with concomitant release of free iron, although the precise 
mechanism of heme degradation by this class of heme oxygenases has not yet been 
delineated (96). Recently it has been suggested that this family of enzymes degrade 
heme via a novel mechanism (81). Porphyrin-bound structures of IsdG-family enzymes 
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have revealed significant ruffling of the porphyrin ring in the active site. In fact, the 
porphyrin ring is distorted approximately 2 Å out of plane, far more than has been 
observed in any other heme-binding protein (53). Moreover, in vitro heme degradation 
catalyzed by recombinant IsdG results in the formation of a yellow reaction product 
distinct from the blue-green biliverdin chromophore (53, 81). Taken together, these 
structural and biochemical observations suggest that members of the IsdG-family of 
heme oxygenases degrade heme by a unique mechanism resulting in the formation of a 
product that is distinct from biliverdin. Herein we present the crystal structure of heme-
bound IsdI and demonstrate that the IsdG-family of enzymes degrade heme to the oxo-
bilirubin chromophore staphylobilin.   
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Methods 
 
Protein purification. Recombinant IsdG and IsdI were purified from Escherichia coli 
BL21(DE3) as previously described (96). Purity was assessed by SDS-PAGE and 
concentrations were determined using a BCA protein assay.  
Crystallography. Crystals of recombinant IsdI-heme were prepared by sitting drop 
vapour diffusion at 4°C. Protein (15 mg/ml in 20 mM Tris-HCl, 0.2 M NaCl) was mixed 
1:1 with a reservoir of 25% polyethylene glycol 3350, 0.2 M MgCl2, and 0.1 M Bis-Tris 
buffer pH 5.5. Prior to data collection crystals were looped from a cryoprotectant of 10% 
ethylene glycol in reservoir solution on ice and immersed in liquid nitrogen. Reduced 
crystals were obtained by soaking the ferric crystals in 50 mM sodium dithionite in 
cryoprotectant solution for 10 minutes before immersion in liquid nitrogen. Diffraction 
data sets were collected under a cryostream at 100 K on beamline 08ID-1 at the 
Canadian Light Source (Saskatoon, SK). The programs in the CCP4 suite (75) were 
used to solve and refine the structures. Data were processed and scaled with MOSFLM 
and SCALA (26), respectively. Initial phases were obtained with the program MolRep, 
using a search model of the protein moiety from the IsdI-CoPPIX structure (PDB ID: 
2ZDP). Model building was carried out using COOT visualization software and the 
structure was refined with the program Refmac5. Final structure validation was done 
with the program PROCHECK and figures were prepared with the program PyMOL.  
Heme degradation and product purification. Heme degradation reactions were 
performed in TBS at room temperature protected from light. IsdG or IsdI (50 µM) were 
incubated with equimolar hemin (Sigma) and catalase (from bovine liver, Sigma) at a 
0.5:1 molar ratio of catalase:hemoprotein. We also performed the reactions in the 
presence of superoxide dismutase (20 units/mL) to test the role of superoxides in the 
heme degradation mechanism. Products and product distributions in reactions 
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performed in the presence of catalase and/or superoxide dismutase were unchanged. 
Ascorbic acid was added to a final concentration of 1 mM and spectral changes between 
300-800 nm were monitored. After 2 hours the reactions were filtered through Centricon 
Plus spin filters (MWCO 5 kDa, Millipore) by centrifugation at 3,220 x g to remove buffer, 
salts, and non-degraded heme. The heme degradation product was eluted from the 
proteins by addition of water:acetonitrile (1:1) with 0.1% trifluoroacetic acid (TFA) 
followed by centrifugation. The eluate was lyophilized and resuspended in a minimum 
volume of water:acetonitrile (1:1) with 0.1% TFA, and further purified by reverse-phase 
chromatography on a Varian ProStar HPLC using a Microsorb-MV C-18 column.  
Biliverdin (MP Biomedicals) and bilirubin (Sigma) were dissolved in 0.1 M NaOH and 
diluted in water:acetonitrile (1:1) with 0.1% TFA for HPLC analysis. 
 HPLC analysis was performed using 95% water / 5% acetonitrile with 0.1% TFA 
as the mobile phase with a flow rate of 1 mL/min.  After a 10 min equilibration period, a 
linear 40 min acetonitrile gradient (5%-80%) was employed and the final concentration 
was maintained for an additional 20 min. The eluant was monitored using a photodiode 
array detector from 200-900 nm and two peaks (λmax: 465nm) were individually 
collected and lyophilized for further analysis. The ratio of isomers was calculated by 
integration of the product peaks and averaged over ten experiments (p < 0.0001). 
LC-MS/MS Analysis. Each lyophilized product was dissolved in acetonitrile:water (1:1) 
with 0.25% formic acid at a concentration of 80 ng/µL prior to injection. The LC-MS/MS 
analysis was performed on a Waters Acquity UPLC system (Waters, Milford, MA) 
integrated with a Thermo Finnigan LTQ linear ion trap mass spectrometer (Thermo 
Fisher Scientific, Waltham, MA) using a Thermo Hypersil Gold C18 column (1.9 µm, 2.1 
x 150 mm). Prior to MS analysis, LC separation was performed using water:acetonitrile 
(95:5) with 0.25% formic acid as the mobile phase. After a 10 µl sample injection, a 20 
minute linear acetonitrile gradient (5%-100%) was performed at a flow rate of 300 µl/min. 
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The following optimized parameters were used for the detection of analyte: N2 sheath 
gas 36 psi; N2 auxiliary gas 20 psi; capillary temperature 300o C; source voltage 3.8 kV; 
source current 100 MA; skimmer offset 0.00 V; capillary offset -44.00 V; tube lens offset 
-103.30 V; activation time 30 ms (MS), 50 ms (MS2); isolation width 1 m/z (MS), 2 m/z 
(MS2). Data acquisition and quantitative spectral analyses were conducted using the 
Thermo-Finnigan Xcaliber software, version 2.0 Sur1. 
NMR. NMR experiments were performed using a 14.0 T Bruker magnet equipped with a 
Bruker AV-III console operating at 600.13 MHz. All spectra with the exception of 13C 
NMR were acquired in 3 mm NMR tubes using a Bruker 5 mm TCI cryogenically cooled 
NMR probe. Chemical shifts were referenced internally to DMSO-d6 (2.49 ppm) which 
also served as the 2H lock solvent. 1D 13C NMR data were acquired using a 14.0 T 
Bruker magnet equipped with a Bruker AV-III console operating at 599.87 MHz using a 
Bruker 5 mm DCH cryogenically cooled NMR probe. For 1D 1H NMR, typical 
experimental conditions included 32K data points, 20 ppm sweep width, a recycle delay 
of 1.5 seconds and 32-256 scans depending on sample concentration. For 2D 1H-1H 
COSY, experimental conditions included 2048 x 512 data matrix, 20 ppm sweep width, 
recycle delay of 1.5 seconds and 4 scans per increment. The data were processed using 
squared sinebell window function, symmetrized, and displayed in magnitude mode. For 
2D 1H-1H nuclear Overhauser enhancement spectroscopy (NOESY), experimental 
conditions included a 2048 x 512 data matrix, a mixing time of 600 ms, 20 ppm sweep 
width, recycle delay of 1.5 seconds and 16 scans per increment. Multiplicity-edited 
HSQC experiments were acquired using a 1024 x 256 data matrix, a J(C-H) value of 145 
Hz which resulted in a multiplicity selection delay of 34 ms, a recycle delay of 1.5 
seconds and 16 scans per increment along with GARP decoupling on 13C during the 
acquisition time (150 ms). The data were processed using a π/2 shifted squared sine 
window function and displayed with CH/CH3 signals phased positive and CH2 signals 
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phased negative. J1(C-H) filtered HMBC experiments were acquired using a 2048 x 256 
data matrix, a J(C-H) value of 9 Hz for detection of long range couplings resulting in an 
evolution delay of 55ms,  J1(C-H) filter delay of 145 Hz (34 ms) for the suppression of 
one-bond couplings, a recycle delay of 1.5 seconds and 128 scans per increment. The 
HMBC data was processed using a π/2 shifted squared sine window function and 
displayed in magnitude mode.    
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Results 
 
The structure of heme-bound IsdI  
We have previously determined the crystal structures of a catalytically inactive 
variant of IsdG bound to heme (FePPIX) as well as native IsdI bound to the heme 
analogue cobalt protoporphyrin IX (CoPPIX) (53). However, studies into the mechanism 
of heme degradation have been hindered by the fact that the crystal structure of a 
catalytically active IsdG-family member bound to the substrate heme has not been 
reported. To gain insight into the mechanism of heme catabolism by IsdG-family 
enzymes, we crystallized the catalytically active IsdI bound to heme by lowering the 
temperature to 4°C. The structure was solved to 1.5 Å resolution with one IsdI dimer in 
the asymmetric unit. The fold of the IsdI-heme complex is similar to that observed in the 
IsdI-CoPPIX structure and the heme porphyrin ring is also highly ruffled. We observe 
elongated density for a sixth iron ligand on the distal side of heme, best modeled as a 
coordinating dioxygen species (Figure 12A-C). The presence of an oxygen species 
implies that heme-iron was photoreduced to Fe(II) in the X-ray beam during data 
collection. Further reduction of the oxygen species is suggested by the elongated Fe-O 
bond length (2.05 Å) and decreases Fe-O-O angle (108º). Notably, dithionite reduced 
crystals yield a structure without a density for a sixth ligand (Figure 12D), likely due to 
the consumption of oxygen in the crystal by the reductant. No other significant 
differences are noted between the dithionite reduced and native structures. 
In contrast to the HO-1 family of enzymes, the oxygen species in the IsdI heme-
binding pocket is aligned with the imidazole plane of the coordinating histidine, which lies 
along the β,δ-axis of the porphyrin ring (Figure 12C). The orientation of the dioxygen is 
restricted by Phe22 and Asn6, which is also an H-bond donor to the oxygen species. In 
the HO-1 family, regiospecificity is also achieved by steric limitations of the dioxygen 
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ligand such that only the α-meso carbon is accessible for hydroxylation (110). In the two 
IsdI heme-binding pockets of the asymmetric unit, the oxygen species are in opposite 
orientations such that the β- or δ-meso carbons are aligned for hydroxylation, a 
regiospecificity distinct from that of the HO-1 family. The heme is bound predominantly in 
one orientation, suggesting that reaction at both meso-carbons is possible.  
Due to the unique placement of the oxygen in the active site, we hypothesized 
that the product of heme degradation by IsdG-family enzymes exhibits unique 
regiospecificity compared to the canonical HO-1 like enzymes. We therefore sought to 
determine the structures of the products of IsdG- and IsdI-mediated heme degradation 
and add insight into the mechanism by which these enzymes degrade heme.   
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Figure 12. Crystal structure of the active site of IsdI-heme. The structure of IsdI 
(green) bound to heme (gray) reveals density on the distal side modeled as a dioxygen 
species (red) liganded to the heme-iron. A. 2Fo - Fc map contoured at 1σ. B. Fo - Fc 
omit map for oxygen is contoured at 3σ. The heme α-, β-, and δ-meso carbons are 
labeled. The γ-meso carbon is buried in the protein. C. The same figure as in b, but 
looking down perpendicular to the heme from the distal side. The heme α-, β-, γ-, and δ-
meso carbons are labeled. D. Crystals of IsdI (cyan) bound to heme (gray) were reduced 
for 10 minutes in 50 mM (excess) dithionite. The 2Fo - Fc map (light gray) is contoured 
at 1σ. Heme and selected amino acids are depicted in sticks and are labeled. Nitrogen, 
oxygen and iron atoms are colored blue, red, and orange, respectively.  
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Purification of the IsdG- and IsdI-catalyzed heme degradation products 
As previous attempts to crystallize the product-bound enzymes were 
unsuccessful, we sought to isolate the product of IsdG-mediated heme degradation for 
structural studies. In vitro heme degradation reactions were performed with purified 
recombinant IsdG and IsdI using ascorbate as the electron donor and catalase to 
prevent coupled oxidation (see Methods). Purification of the products of IsdG- and IsdI-
catalyzed heme degradation results in a red-orange solid that becomes yellow when 
dissolved in dimethyl sulfoxide (DMSO) or water:acetonitrile (1:1). This is in stark 
contrast to the blue-green color of the canonical heme degradation product biliverdin 
(Figure 13A-C, insets). HPLC-separation of the IsdG and IsdI reaction products results in 
two distinct peaks which elute earlier than both biliverdin and bilirubin, indicating a higher 
degree of polarity (Figure 13A-C). Product peaks from both IsdG- and IsdI-mediated 
degradation exhibit similar optical spectra with one maximum at ~390 nm and one at 
~460 nm. The peak maxima of biliverdin are 365 and 663 nm and the peak maximum of 
bilirubin is 446 nm (Figure 13D-F). Together, these data suggest that the IsdG-family of 
oxygenases catabolize heme to a unique chromophore that is more polar than biliverdin 
and bilirubin. 
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Figure 13. Purification and optical spectra of heme degradation products. HPLC 
tracings of heme degradation products separated on a linear acetonitrile gradient. Insets 
are images of products dissolved in DMSO in 3 mm NMR tubes. The contrast of the 
photos was adjusted to present the clearest image.  A. Biliverdin purification monitored 
at 405 nm. B. Bilirubin purification monitored at 405 nm. C. The product of IsdI-catalyzed 
heme degradation monitored at 465 nm. The two prominent peaks were collected 
separately. IsdG- and IsdI-catalyzed heme degradation products have overlapping 
spectra so only that of IsdI is shown for simplicity. D-F. Optical spectra of each fraction 
as measured by the photodiode array detector upon elution. 
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IsdG and IsdI degrade heme to staphylobilin 
To determine the molecular composition of the products of IsdG- and IsdI-
mediated heme degradation, the HPLC-purified samples were subjected to high 
resolution electrospray ionization mass spectrometry (HRESIMS). Each of the eluting 
product peaks gave a mass of 598.25 Da (m/z 599.2605 [M + H], Δ = 3.0 - 4.2 ppm), 
corresponding to a molecular formula of C33H34N4O7 (data not shown). As biliverdin and 
bilirubin have molecular masses of 582.6 and 584.7 Da, respectively, these data 
conclusively demonstrate that heme degradation catalyzed by IsdG and IsdI does not 
produce biliverdin or bilirubin.  
This hypothesis is supported by analysis of 1H NMR spectra of the purified 
fractions acquired in d6-DMSO. Inspection of the downfield region indicates that both 
eluting fractions possess two pyrrol amide (δ 10.4 – 10.5) and two pyrrol amine (δ 11.0 – 
11.3) resonances; however notable chemical shift differences in this region were evident 
between the two fractions (Figure 14). Furthermore, both products of IsdG- and IsdI-
mediated heme degradation have distinct 1H NMR spectra in comparison to bilirubin 
(Figure 14A) (46). The most significant dissimilarity is again in the NH region in which 
the pyrrol amines of the IsdG and IsdI products are shifted as much as 0.8 ppm in 
comparison to reported hemes (Figure 14). Chemical shift values in this range are also 
observed in 10-oxo-mesobilirubin which was chemically synthesized by Chen et al. in 
order to investigate possible oxidative pathways of bilirubin elimination in vivo (10). Due 
to the addition of a carbonyl group at the γ-meso carbon of bilirubin, 10-oxo-
mesobilirubin is more stable than the parent molecule and the pyrrole NHs are 
considerably more deshielded than the corresponding NHs of bilirubin (10). These 
similarities further suggest that the products of IsdG-mediated heme degradation may be 
oxidized forms of bilirubin.  
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Figure 14. 1H NMR spectra comparing downfield regions of heme degradation 
products. Comparison of the downfield regions of bilirubin (A), IsdG peak 1 (B), IsdG 
peak 2 (C), IsdI peak 1 (D), and IsdI peak 2 (E). 
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The 1H NMR spectra also establish several regions of biliverdin and bilirubin that 
are conserved in the IsdG-family products. All side-chain resonances present 
comparable chemical shifts and coupling values to canonical hemes (Tables 2 and 3), 
indicating that the vinyl side chains and the α- and β-CH2 positions of the propionate 
group chains are intact and that the methyl substituents are unmodified. Side-chain 
functional groups are readily positioned in their corresponding pyrrol rings using two-
dimensional NMR data (Figure 15A). The observed nuclear Overhauser effect (NOE) 
interactions between C20-CH and C3-CH3 and also C18-CH= indicate that the α-bridge 
is intact, and correlations between C10-CH and α,α’-CH2, β,β’-CH2 indicate that the γ-
bridge is intact (Figure 15A). These spectral data allow us to assemble two partial 
structures, one hemisphere containing the intact α-bridge and the other encompassing 
the intact γ-bridge (Figure 15B). Therefore, although the IsdG-family heme degradation 
products share structural similarities with bilirubin, these products are not cleaved at the 
α-meso carbon. 
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Figure 15. NOESY correlations of IsdG product peak 1. A. NOESY spectrum (in d6-
DMSO) of the first eluting product focused on key regions that demonstrate correlations 
between the α- and γ-bridge CHs and neighboring protons. The second eluting product 
from the IsdG-catalyzed reaction and the IsdI-catalyzed products have similar NOESY 
spectra. B. Two fragments of a bilirubin-like molecule with NOE correlations (arrows). 
Carbon 10 and 20 are labeled according to standard bilirubin nomenclature in which C10 
corresponds to the γ-meso carbon and C20 corresponds to the α-meso carbon of the 
porphyrin ring. 
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From the molecular formula obtained by HRESIMS and the NMR data described 
above, we have been able to propose structures of the products of IsdG- and IsdI-
mediated heme degradation. In accordance with the 10-oxo-mesobilirubin nomenclature 
(10), we have named these unprecedented molecules 5-oxo-δ-bilirubin (elution peak 1) 
and 15-oxo-β-bilirubin (elution peak 2) (Figure 16). Collectively, we refer to these 
molecules as staphylobilins. The β- and δ-meso carbon cleavage is in agreement with 
the alignment of molecular oxygen in two orientations along the β,δ-heme axis in the 
crystal structure of heme-bound IsdI (Figure 12C). Alternatively, the heme molecule may 
bind in either orientation about the α,γ-axis in the active site, resulting in either the β- or 
δ-isomer of oxo-bilirubin, as reported previously for the CoPPIX and inactive IsdG 
variant (53). Similarly, in human HO-1, heme is orientationally disordered about the α,γ-
axis, although in that case α-cleavage occurs with either heme seating (91).  
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Figure 16. Structures of heme degradation products. A. Bilirubin. B. 5-oxo-δ-
bilirubin, the first eluting product. C. 15-oxo-β-bilirubin, the second product to elute upon 
HPLC purification. The bilirubin carbon numbering scheme was used for the IsdG and 
IsdI products for simplicity. D. Three-dimensional representation of 5-oxo-δ-bilirubin. The 
carbons, nitrogens, and oxygens have been colored black, teal, and pink, respectively. 
The structure was adjusted to minimize the cumulative potential energy for the model.  
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Table 2. 1H and 13C data of 5-oxo-δ-bilirubin 
 
Positiona 
1H, m 
(J in Hz) 
13C 
(ppm) COSY HMBC NOESY 
13, CH3 1.80, s 7.9 - 
126.7, 144.3, 
172.0 2.79 
7, CH3 1.92, s 9.1 - 125.3, 131.7 2.76, 11.30 
17, CH3 1.93, s 9.1 - 140.3, 171.6 5.71 
2, CH3 2.22, s 10.8 - - 5.37, 6.18 
8, α CH2 
2.36, t 
(7.1) 34.4 2.76 126.7, 173.4 2.76, 6.12 
12, α' CH2 
2.46, t 
(7.5) 33.5 2.79 144.3, 173.1 2.79, 6.12 
8, β CH2 
2.76, d 
(7.0) 18.5 2.36 - 1.92, 2.36 
12, β' CH2 
2.79, d 
(7.0) 18.5 2.46 144.3, 173.1 1.80, 2.46 
3, =CH2 cis 
5.13, dd 
(1.6, 11.7) 115.2 6.60 125.1 5.37, 6.60 
3, =CH2 
trans 
5.37, dd 
(1.7, 18.0) 115.2 6.60 125.1 2.22, 5.13 
18, =CH2 
trans 
5.68, dd 
(1.4, 13.5) 122.7 6.86 140.3 1.93 
18, =CH2 cis 
5.71, dd 
(1.5, 7.4) 122.7 6.86 140.3 6.86 
5 - 174.7 - - - 
10 6.12, s 95.9 - 126.7, 144.3 2.36, 2.46, 2.79, 11.30 
20 6.18, s 96.8  121.4, 140.3 2.22, 6.86 
3, -CH= 6.60, dd (11.7, 18.0) 128.2 
5.13, 
5.37 121.4 5.13 
18, -CH= 6.86, dd (11.6, 17.6) 126.5 
5.68, 
5.71 125.8 5.71, 6.18 
23 NH 10.40, s - - 126.7, 132.5, 144.3 11.04, 11.30 
24 NH 10.48, s - - 125.8, 131.7, 140.3 11.04, 11.30 
21 NH 11.04, s - - 125.1, 127.6, 131.6 10.40, 10.48 
22 NH 11.30, s - - 120.4, 125.3 1.92, 6.12, 10.48, 10.40 
8, COOH 12.09, bs 173.4 - - - 
12, COOH 12.09, bs 173.1 - - - 
 
a. Position based on numbering scheme in Figure 16 
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Table 3. 1H and 13C data of 15-oxo-β-bilirubin 
 
Positiona 
1H, m  
(J in Hz) 
13C 
(ppm) COSY HMBC NOESY 
7, CH3 1.81, s 7.8 - 
126.6, 144.3, 
172.0 2.79 
13, CH3 1.99, s 9.5 - 
124.8, 127.5, 
131.3 2.79 
17, CH3 2.05, s 11.0 - 122.9, 132.5 - 
2, CH3 2.18, s 8.8 - 
124.2, 133.6, 
142.1 - 
12, α CH2 
2.37, m  
(1.8) 34.3 2.79 18.4, 173.3 2.79 
8, α' CH2 
2.46, d 
(7.6) 33.4 2.79  18.6, 172.9 - 
8, β CH2 
12, β' CH2 
2.79, q  
(7.2, 12.0) 
18.4, 
18.6 
2.37, 
2.46 
33.4, 126.6, 
144.3, 173.3 1.81, 1.99, 2.37 
18, =CH2 
cis 
5.35, dd 
(1.5, 11.6) 115.8 6.87 124.8 - 
3, =CH2 cis 
5.38, d 
(2.3) 118.6 6.60 124.2 6.24 
18, =CH2 
trans 
5.41, dd 
(1.6, 17.6) 115.8 6.87 - 6.24, 6.87 
10 6.12, s 95.8 - 126.6, 144.3 2.79 
15 - 174.9 - - - 
20 6.24, s 97.1 - 124.2, 142.1 2.18, 5.38, 6.87 
3, =CH2 
trans 
6.25, dd 
(2.4, 17.5) 118.6 6.60 124.2 2.18, 5.38 
3, -CH= 6.60, dd (11.6, 17.6) 126.2 5.38 - - 
18, -CH= 6.87, dd (11.6, 17.8) 128.3 
5.35, 
5.41  - 5.41, 6.24 
21 NH 10.47, s - - 124.2, 132.4, 142.1 11.05, 11.28 
22 NH 10.47, s - - 124.2, 132.4, 142.1 11.05, 11.28 
23 NH 11.05, s - - 126.6 10.47, 11.28 
24 NH 11.28, s - - 122.9, 124.8 10.47, 11.05 
8, COOH 12.09, bs 172.9 - - - 
12, COOH 12.09, bs 173.3 - - - 
 
a. Position based on numbering scheme in Figure 16 
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The position of the remaining oxygen atom in the proposed structures of β- and 
δ-oxo-bilirubins was confirmed by tandem ESI-MS analyses and two-dimensional NMR 
(Figures 17 and 18). Fragmentation generated by collision-induced dissociation results 
in cleavage on either side of the proposed dipyrryl ketone and is diagnostic for the 
presence of the 5- and 15-oxo-bridges in these structures. Fragmentation at these 
positions results in the formation of ion pairs consisting of an oxonium ion (m/z 359, 267 
[M+]) and pyrrolium ion (m/z 241, 333 [M’+H]). Pyrrolium ions M’ correspond to ions 
resulting from intramolecular proton transfer reactions, possibly facilitated by propionate 
groups which are proximal in the ridge-tile conformation (10). Beta-fragmentation of the 
β-propionic acid side chains is also evident (m/z 539.2), as has been noted in the mass 
spectral analysis of analogous mesobiliverdin (17). Lastly, we observe cleavage at the 
C-10 methine bridge (m/z 418.2), similar to that observed in mesobiliverdin (17). The 5- 
and 15-oxo-bridges in these structures were further confirmed by observation of a fifth 
carbonyl resonance in 5-oxo-bilirubin at 175.1 ppm via cryogenic 13C-NMR (Tables 2 
and 3), consistent with the reported shift of the oxo-bridge in 10-oxo-bilirubin at 176 ppm 
(10).  
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Figure 17. Tandem LC-HRESIMS of staphylobilin. A. ESI-MS/MS spectrum of 
fragment ions selecting for 599.3 m/z for 5-oxo-δ-bilirubin. B. ESI-MS/MS spectrum of 
fragment ions selecting for 599.3 m/z for 15-oxo-β-bilirubin. C,D. Fragmentation scheme 
corresponding to the masses and molecular formulas obtained in A and B respectively. 
ESI-MS/MS spectra for IsdI-catalyzed products are similar.  
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Figure 18. Two-dimensional NMR correlations of IsdG products. A. 5-oxo-δ-bilirubin 
COSY correlations (solid lines) and HMBC correlations (dashed lines). B. 5-oxo-δ-
bilirubin NOESY correlations. C. 15-oxo-β-bilirubin COSY correlations (solid lines) and 
HMBC correlations (dashed lines). D. 15-oxo-β-bilirubin NOESY correlations. IsdI 
products have similar 2D NMR spectra. 
 
 
 79 
Discussion 
 
In this study we presented the crystal structure of native IsdI bound to heme and 
described HRESIMS and NMR studies on the products of IsdG- and IsdI-catalyzed 
heme degradation. Combined, these data demonstrate that IsdG and IsdI degrade heme 
to release a mixture of β- and δ- isomers of oxo-bilirubin. To the best of our knowledge, 
these oxo-bilirubin isomers have not been previously observed or characterized.  
 It has been reported that IsdG-mediated heme degradation results in the 
formation of biliverdin based on similar HPLC elution profiles between these molecules 
(96). However, the prior study utilized standard methods for isolating biliverdin, which 
includes a chloroform extraction. In these studies we have found that staphylobilin is not 
very soluble in chloroform, and therefore, the previously published chromatograms are 
not representative of purified staphylobilin. Moreover, the previous chromatographic 
method used a methanol:water mobile phase and monitored absorbance at 380 nm. In 
the current study we have used an acetonitrile:water mobile phase and 465 nm, which 
better distinguishes the two products. We believe it is for these reasons that the product 
of IsdG-mediated heme degradation was previously misassigned as biliverdin. 
The HRESIMS data provide conclusive evidence that heme degradation 
catalyzed by IsdG-family enzymes does not result in the canonical heme degradation 
product biliverdin or the eukaryotic metabolite bilirubin. The UV/VIS and downfield 
regions of the 1H NMR spectra demonstrate that the IsdG-family products share 
similarities with 10-oxo-mesobilirubin (Figures 13 and 14) (10). Moreover, the hetero-
nuclear multiple bond coherence (HMBC) and NOESY spectra demonstrate an intact 
correlation network between the α-meso carbon proton and the vinyl protons at C18 and 
methyl protons at C2. The γ-meso proton also displays correlations with the propionate 
side chain protons of rings B and C (Figure 15 and 18). These data provide strong 
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evidence that the α- and γ-meso carbons of the porphyrin ring are intact, accounting for 
all but 28 Daltons of the isolated heme degradation products. ESI-MS/MS data and 13C 
NMR spectra demonstrate that the remaining mass comprises a bridging carbonyl (C=O) 
between the α/γ positions in the two isomers (data not shown).  
 The mechanism of the HO-1 family of enzymes has been studied extensively, 
although surprisingly, many details remain unclear (Figure 19) (111, 120). After the 
enzyme binds ferric-heme, one electron is donated by the reducing substrate, converting 
heme-iron to the ferrous state. Molecular oxygen then binds the reduced 
pentacoordinate heme to form a meta-stable oxy complex. From there, a one electron 
reduction and protonation yields a ferric-hydroperoxo complex. This complex then self-
hydroxylates at the α-meso carbon, although it is unknown how the protonation activates 
the hydroperoxo intermediate to promote meso-hydroxylation. Ferric α-meso-
hydroxyheme is then converted to biliverdin through multiple oxidoreductive steps and a 
verdoheme intermediate (58, 91, 111). The conversion of verdoheme to biliverdin is 
incompletely understood, although it is known to be the rate-limiting step of the reaction 
in vivo (111). However, in vitro the rate-limiting step is biliverdin release. In mammals 
this step is accelerated by biliverdin reductase, which removes biliverdin from the active 
site and reduces it to bilirubin. All characterized bacterial heme oxygenases catalyze 
single-turnover reactions in vitro, suggesting that another protein is required to remove 
the heme degradation product from bacterial heme oxygenases in vivo (76, 121). 
Both IsdG-like and HO-1-like enzymes produce biliverdin derivatives suggesting 
that both reactions may proceed similarly up to formation of a hydroperoxo intermediate. 
However, in the case of IsdG-like enzymes the complex would self-hydroxylate at the β- 
or δ-meso carbon, rather than the α-meso carbon. Importantly, HO-1-like enzymes 
contain an ordered set of water molecules in the binding pocket that funnel protons to 
the catalytic site and stabilize the hydroperoxy intermediate (33, 51)
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is absolutely required for catalysis in all HO-1 enzymes (58, 91, 92, 103); however, a 
similar water network is not present in IsdG-family enzymes (53). Therefore, it is 
currently unclear how intermediates are activated and stabilized during IsdG-mediated 
catalysis.  
It is possible that the meso-hydroxyheme intermediate may then go through a 
verdoheme intermediate that is hydroxylated and then degraded to staphylobilin, or 
through formation of a β,δ-dihydroxyheme intermediate that is subsequently degraded to 
staphylobilin (Figure 19). Addition of biliverdin to purified IsdG and ascorbate does not 
lead to the formation of staphylobilin (data not shown), indicating that α-biliverdin is not 
an intermediate in the pathway. However, more experiments are necessary to elucidate 
the mechanism of staphylobilin formation. 
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Figure 19. Mechanisms of heme oxygenases. The mechanism of the HO-1 family of 
heme oxygenases is highlighted in gray. The proposed IsdG-family mechanism follows 
the same pathway up to the ferric hydroperoxo heme intermediate. From there, β-meso-
hydroxyheme may be formed, which could then follow one of two pathways, ultimately 
resulting in production of staphylobilin. 
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In the active site of IsdI there are several amino acids that are completely 
conserved among members of the IsdG-family of enzymes, including Asn6. We 
hypothesize that the conserved asparagine has two roles in heme catalysis. The 
asparagine amide is observed to form an H-bond to the bound oxygen species and 
potentially stabilizes intermediate(s) in the pathway. Asn6 along with Phe22 may also 
sterically direct the sites of hydroxylation, as they are only 3.5 Å from the α- and γ-meso 
carbons, respectively (Figure 12). Phe22 is conserved in all IsdG members with the 
exception of HmuD and HmuQ from B. japonicum, which encode for tryptophan at that 
site. Though the precise nature of the oxygen species observed in the crystal structure 
remains to be characterized, the steric constraints imposed by Asn6 and Phe22 are 
likely to be structurally conserved leaving only the β- and δ-meso carbons accessible for 
hydroxylation. Indeed, Phe22 is one of the residues implicated in directing heme ruffling 
such that the β- or δ-meso carbons are tilted towards the oxygen species (53). 
Considering that the pathway of heme degradation has not been experimentally 
determined, identification of the reaction products of IsdG-family enzymes raises many 
mechanistic questions to be investigated in future studies.  
Interestingly, we noted that 67.5 ± 1.9% of the IsdG-catalyzed product elutes in 
the first peak as the δ-isomer, whereas only 56.2 ± 1.6% of the IsdI-catalyzed product 
elutes as the δ-isomer. This may indicate that the heme-binding pocket of IsdG is more 
constricted than that of IsdI, and therefore preferentially allows for one heme seating 
over another. The ramifications for this regiospecificity in vivo and the fate and function 
of staphylobilin inside the cell are currently under investigation. 
Bilirubin, the terminal product of heme degradation in mammals, is one of the 
most potent antioxidants in the serum (101). The other products of vertebrate heme 
catabolism, biliverdin and carbon monoxide, also have beneficial antioxidative and anti-
inflammatory properties (47). In fact, only one instance of an HO-1 deficient human has 
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been reported, indicating that HO-1 deficiency is most likely lethal in utero (63). In 
contrast, the role of bacterial heme degradation products in vivo has yet to be 
uncovered. Considering the important roles of biliverdin and bilirubin within vertebrate 
cells, it is tempting to speculate that staphylobilins may have important functions within 
bacterial pathogens. This is particularly intriguing considering that IsdG and IsdI are 
differentially regulated in response to environmental changes experienced by the 
bacterium (80). It is possible that the different isomers of staphylobilin are required under 
different environmental conditions. Moreover, the significant difference in protein 
structure and mechanism between human HO-1 and the IsdG-family of enzymes, 
combined with the known requirement for IsdG-mediated heme degradation during 
bacterial pathogenesis (80, 95), suggests that inhibiting this class of bacterial HOs is an 
attractive therapeutic strategy.   
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CHAPTER V 
 
THE INTRACELLULAR FATE OF NON-DEGRADED METALLOPORPHYRINS 
 
Introduction 
 
In iron-restricted environments Staphylococcus aureus can degrade exogenously 
acquired heme for use as a nutrient iron source. However, heme is also valuable to S. 
aureus in its intact form (81). This supposition is based on the requirement for heme as a 
cofactor in numerous bacterial proteins. The majority of heme-binding proteins are 
cytochromes located within the plasma membrane (106). When iron is not limiting 
bacteria may utilize exogenous heme as an enzyme cofactor, as it is thermodynamically 
favorable to import host heme rather than synthesize the porphyrin ring de novo. In fact, 
it has been shown that when radiolabeled heme is added to cultures of Bacillus subtilis, 
heme is taken up and incorporated into four distinct cytochromes (84). Moreover, some 
pathogens, such as Enterococcus faecalis and Group B Streptococcus, rely solely on 
exogenously acquired heme for respiration (123, 126).  
A role for exogenously acquired heme in staphylococcal hemoproteins is 
supported by the observation that heme-iron is preferentially acquired and segregated 
intact to the plasma membrane when other iron sources are simultaneously available 
(97). The molecular mechanisms required for trafficking heme to the membrane of Gram 
positive bacteria are not fully understood. Moreover, the cytochrome profile of S. aureus 
has not been studied in detail. Based on the requirement for heme in staphylococcal 
pathogenesis, determining the fate of intact heme in the membrane may lead to the 
discovery of novel therapeutic targets. We hypothesize that the subcellular fate of heme 
is dependent upon the environmental conditions experienced by the bacterium.  
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Methods 
 
Bacterial strains and growth conditions.  S. aureus clinical isolate Newman was used in 
all experiments (24). Bacteria were grown in TSB at 37°C with shaking at 180 rpm 
unless otherwise stated. 
Electron microscopy (EM). S. aureus was grown overnight in iron-rich TSB, iron-deplete 
TSB containing 1 mM dip, or iron-deplete TSB supplemented with heme (10 µM). The 
cultures were pelleted and washed several times with fixative buffer. Finally, fixative 
buffer was added to the samples, which were then submitted for sectioning and staining 
at the Vanderbilt EM Core.  
Degradation of Metalloporphyrin. IsdG and IsdI were expressed in Escherichia coli BL21 
(DE3) and purified as previously described (96). Metalloporphyrins (Frontier Scientific) 
were dissolved in 0.1 N NaOH (10 mM) and spectra were obtained with a Varian Cary 
50-BIO UV-visible spectrophotometer from 300 to 700 nm. For degradation studies 
purified protein (10 µM) was combined with dissolved metalloporphyrin (10 µM) in TBS 
and allowed to bind for 1 hour at 4°C. Initial spectra were obtained, followed by addition 
of ascorbic acid (1 mM) as an electron donor. Spectra were obtained every 5 minutes for 
90 minutes. For spectra of metalloporphyrins alone, the same procedure was used 
without the addition of purified protein. 
Inductively-coupled plasma mass spectrometry (ICP-MS) tracking. All Teflon tubes were 
incubated in 6 N HCl for 2 weeks and then washed at least 5 times with deionized water 
to remove all metals. Overnight cultures of S. aureus grown in iron-replete TSB or iron-
deplete TSB (1 mM dip) media were washed and normalized by optical density (OD). 
Bacteria were then subcultured into iron-replete or iron-deplete media containing Ga-
PPIX (2.0 µg/mL) and were incubated at 37°C for 4 hours. The cultures were then 
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normalized and pelleted. The supernatants were removed and concentrated at room 
temperature in Teflon tubes. The pellets were then washed three times in TBS and 
transferred to flat-bottom Teflon tubes. The cell wall was removed by lysostaphin (0.1 
mg) treatment in TSM, followed by pelleting. The cell wall fraction (supernatant) was 
transferred to Teflon tubes while the pellets were resuspended in TBS and sonicated, 
followed by ultracentrifugation (100,000 x g) for 1 hour. The cytoplasmic fractions 
(supernatant) were transferred to clean Teflon tubes and the membrane fractions 
(pellets) were resuspended in TBS. Nitric acid (1 mL, Optima) and hydrogen peroxide 
(100 µL) were added to each Teflon tube and samples were boiled at 130°C until dry. 
Dried samples were sent for analysis by ICP-MS.  
Growth analysis and lactate production. Overnight cultures of S. aureus were 
subcultured in triplicate (1:100) into TSB supplemented with Ga-PPIX (0, 0.1, 1, 10 µM). 
For aerobic growth, cultures were inoculated into 50 mL TSB in 250 mL flasks. For 
anaerobic growth, bacteria were inoculated into 5 mL TSB in 6–well plates and 
incubated with AnaeroGen (Oxoid Ltd, England) compact atmosphere generating 
pouches. Growth was measured after 24 hours by optical density (OD) at 600 nm using 
a Cary 50 MPR microplate reader coupled to the Varian Cary 50-BIO UV-visible 
spectrophotometer. Following incubation, the cultures were pelleted and supernatants 
were collected. Lactate was measured using the Lactate Assay Kit (University at Buffalo) 
according to manufacturer’s instructions. Cultures exposed to 10 µM heme did not grow 
well enough to analyze the lactate concentration of the supernatants. 
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Results 
 
Exogenously acquired heme can be visualized by electron microscopy. 
 In an attempt to visually track the subcellular localization of exogenously 
acquired heme, I grew S. aureus to stationary phase and then prepared samples for 
sectioning and staining at the Vanderbilt Electron Microscopy (EM) core. S. aureus 
grown in iron-rich medium appear normal with electron-dense regions near the center of 
the cells, likely representing nucleoid material (data not shown). However, S. aureus 
grown in iron-deplete medium supplemented with heme exhibit striking electron-dense 
foci near the periphery of the cells (Figure 20). The foci are not due to the iron chelator, 
as cells grown in iron-deplete medium alone appear identical to bacteria grown in iron-
rich conditions (data not shown). Based on these observations, we conclude that these 
are heme-dependent foci localized near the plasma membrane. We hypothesize that 
these foci represent an accumulation of exogenously acquired heme that is specifically 
trafficked to membrane-localized proteins.  
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Figure 20. Transmission electron microscopy of S. aureus grown in the presence 
of heme. Wild type S. aureus was grown overnight in iron-deplete media containing 
heme. Arrows point to electron-dense foci that are specific to bacteria grown in heme. 
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Non-iron metalloporphyrins remain intact in S. aureus 
 
 Non-iron metalloporphyrins are comprised of the same tetrapyrrole as heme, with 
a substitution for the central coordinated metal. A seminal paper by Igor Stojiljkovic and 
colleagues demonstrated a potent antibacterial effect of non-iron metalloporphyrins 
against pathogenic bacteria, including several multi-drug resistant clinical isolates of S. 
aureus (102). It was hypothesized that these heme-like molecules act as ‘‘molecular 
Trojan horses’’ that enter bacteria through heme transport systems where they then 
exert their antibacterial effect in the cytoplasm or membrane (102). The potent 
antibacterial effect of metalloporphyrins suggests that these molecules target vital 
cellular processes inside the bacteria, which may represent novel therapeutic targets 
against S. aureus infection. Additionally, due to their similarity to heme, we hypothesized 
that metalloporphyrins may be useful as surrogates for heme trafficking. To this end, we 
first sought to determine if these heme-like molecules can be degraded inside the cell by 
the heme oxygenases IsdG and IsdI.  
 In vitro metalloporphyrin binding experiments were performed with equimolar 
concentrations of heme oxygenase and metalloporphyrin. We tested several toxic 
metalloporphyrins, including gallium protoporphyrin IX (Ga-PPIX), manganese 
protoporphyrin IX (Mn-PPIX), and zinc protoporphyrin  IX (Zn-PPIX), as well as the non-
toxic compound cobalt protoporphyrin IX (Co-PPIX) (102). As previously reported, we 
found that purified recombinant IsdG and IsdI rapidly degrade heme (Fe-PPIX) in the 
presence of electron donor (Figure 21A). In contrast, neither enzyme was able to 
degrade any of the non-iron metalloporphyrins tested (Figure 21B-E). This lack of activity 
was despite the fact that all of these metalloporphyrins are bound by IsdG and IsdI as 
evidenced by alterations in the visible absorption spectra upon co-incubation of enzyme 
with metalloporphyrin. Notably, Co-PPIX, Ga-PPIX, and Zn-PPIX undergo spectral 
changes upon exposure to ascorbate, and these changes are inhibited by complex 
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formation with IsdG or IsdI. Taken together, these results demonstrate that despite the 
fact that IsdG and IsdI complex non-iron metalloporphyrins in vitro, the catabolic activity 
of IsdG and IsdI is specific for Fe-PPIX. Therefore, the antibacterial effect of non-iron 
metalloporphyrins is not due to the released metal ion upon tetrapyrrole cleavage, but 
rather, due to an effect of the intact metalloporphyrin. 
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Figure 21. Binding of non-iron metalloporphyrins by IsdG and IsdI. In vitro 
enzymatic degradation of several metalloporphyrins was analyzed via UV-visible 
spectrophotometry. IsdG- and IsdI-mediated degradation of Fe-PPIX (A), Co-PPIX (B), 
Ga-PPIX (C), Mn-PPIX (D), and Zn-PPIX (E) was analyzed after addition of ascorbate as 
an electron donor. Red lines indicate absorbance (Abs) before addition of electron 
donor. Blue lines indicate absorbance after 90 minutes in the presence of ascorbate. 
Adapted from Lee et al. 2008 (53). 
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Ga-PPIX is specifically trafficked to the plasma membrane. 
 
The metalloporphyrin degradation assay suggests that non-iron 
metalloporphyrins may be useful as surrogate molecules for tracking the subcellular 
localization of intact heme. We chose Ga-PPIX for this analysis because, unlike iron, 
cobalt, manganese, and zinc, gallium is not found in nature at detectable levels, making 
the background of our experiment minimal.  
We have previously shown that heme is specifically segregated to the membrane 
when S. aureus is grown under iron-replete conditions (97). To determine if Ga-PPIX 
trafficking mimics that of heme, we utilized inductively-coupled plasma mass 
spectrometry (ICP-MS) to track the gallium atom of the non-iron metalloporphyrin Ga-
PPIX. ICP-MS is a highly sensitive technique that is capable of quantifying atoms in a 
complex mixture at concentrations as low as one part per trillion. Specifically, S. aureus 
was grown in iron-restricted media supplemented with either Ga-PPIX or gallium salt 
Ga(NO3)3. Cells were divided into cell wall, membrane, and cytoplasmic fractions and 
were analyzed by ICP-MS in order to determine the quantity of gallium in each fraction. 
We found significantly more gallium in whole cell S. aureus grown in Ga-PPIX than in 
bacteria grown in gallium salt (15.9% versus 4.5% of the media gallium content), 
although quantities of gallium added to the media prior to bacterial growth are similar 
(Figure 22A). This supports the hypothesis that S. aureus actively imports the non-iron 
metalloporphyrin similarly to heme under iron-restricted conditions. Furthermore, the 
majority of the gallium from Ga-PPIX localizes to the membrane fraction (52%), whereas 
the majority of gallium from the salt localizes to the cell wall (Figure 22B). From these 
results we conclude that Ga-PPIX is actively acquired and preferentially sorted to the 
plasma membrane.  
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Figure 22. ICP-MS tracking of Ga-PPIX. A. Quantification of gallium atoms in media 
and whole cell S. aureus, as determined by ICP-MS analysis. B. Percentage of total 
gallium in each fraction. Error bars represent the standard deviation of three 
independent samples. Asterisks represent statistically significant differences between 
Ga-PPIX and Ga(NO3)3 localization, as determined by Student’s t test (* p < 0.02, ** p < 
0.05). 
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Ga-PPIX toxicity is dependent on aerobicity. 
 The antibacterial activity of several metalloporphyrins has been established, 
although the mechanism of toxicity is not yet understood (102). In an effort to determine 
the mechanism of Ga-PPIX toxicity, I analyzed the growth of S. aureus in iron-deplete 
medium supplemented with various concentrations of Ga-PPIX. As expected, Ga-PPIX 
inhibits S. aureus growth in a dose-dependent manner (data not shown). It was 
previously demonstrated that anaerobically grown E. coli are resistant to non-iron 
metalloporphyrins, suggesting that these compounds are only toxic to actively respiring 
bacteria (102). To test the susceptibility of anaerobic S. aureus to Ga-PPIX, bacteria 
were grown in iron-deplete medium supplemented with Ga-PPIX in well-aerated flasks or 
anaerobic cultures. Ga-PPIX inhibits S. aureus growth in aerobic conditions significantly 
more than when grown anaerobically (Figure 23A). However, unlike E. coli, anaerobic S. 
aureus is not fully resistant to Ga-PPIX, suggesting that the mechanism of Ga-PPIX 
toxicity may be different between the two bacteria.  
Ga-PPIX is preferentially sorted to the plasma membrane and exerts greater 
toxicity when S. aureus is actively respiring. Therefore we hypothesized that Ga-PPIX is 
incorporated into membrane-localized cytochromes in place of heme. Gallium lacks the 
redox potential of iron, consequently the incorporation of Ga-PPIX would be expected to 
disrupt electron transport during respiration. The disruption of respiration may lead to an 
accumulation of reactive oxygen species and the observed toxicity. To circumvent this, 
S. aureus is capable of switching to fermentative metabolism. Fermentation leads to the 
accumulation of lactate and minor amounts of pyruvate, acetate, and acetoin (105). To 
test the hypothesis that Ga-PPIX inhibits respiration, I measured the lactate produced 
from overnight cultures of S. aureus grown aerobically or anaerobically in the presence 
of Ga-PPIX. As expected, S. aureus produces significantly more lactate when grown in 
an anaerobic environment as compared to bacteria grown aerobically (Figure 23B). In 
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support of our hypothesis, I observed that S. aureus grown in an aerobic environment 
increases lactate production in a dose-dependent manner when exposed to Ga-PPIX 
(Figure 23B). These results indicate that Ga-PPIX induces S. aureus to undergo 
fermentative metabolism, suggesting that the antibacterial effect of Ga-PPIX may be due 
to inhibition of respiration. 
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Figure 23. Ga-PPIX toxicity is dependent on aerobicity. A. S. aureus growth in Ga-
PPIX is graphed as a percentage of growth in the absence of Ga-PPIX. B. The lactate 
concentration of supernatants from overnight cultures of S. aureus was measured. 
Asterisks indicate statistically significant differences between aerobic and anaerobic 
conditions, as measured by Student’s t test (*p < 0.01; ns, p > 0.3).  
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Discussion 
 
 It is now established that many bacterial pathogens, including S. aureus, import 
and degrade host heme for use as a nutrient iron source (29, 98). Data is now beginning 
to emerge indicating that the fate of heme inside the cell is multifaceted, although the 
mechanisms of intracellular heme trafficking are poorly understood. Endogenous heme 
synthesis, intracellular heme degradation, and non-heme iron stores make tracking 
exogenously acquired heme inside the cell technically difficult. To this end, I have 
demonstrated that the non-iron metalloporphyrin Ga-PPIX is a viable surrogate molecule 
for heme tracking. Moreover, IsdG and IsdI are incapable of degrading non-iron 
metalloporphyrins such as Ga-PPIX, enabling us to specifically localize the intact 
porphyrin (Figure 21).  
S. aureus is known to segregate exogenously acquired heme to the plasma 
membrane (97). I have demonstrated that under similar conditions the heme analogue 
Ga-PPIX is actively imported and sorted to the plasma membrane. This is in contrast to 
Ga(NO3)3 which enters the cell passively, as evidenced by the low amount of 
intracellular gallium and its localization to the cell wall (Figure 22). These results 
establish Ga-PPIX as a valuable laboratory tool for investigating the intracellular fate of 
intact heme.  
In addition to the laboratory setting, it has been shown that metalloporphyrins 
may have utility in the clinic. In a mouse model of burn wound infection, topical 
application of a heme-deuterophorphyrin mixture reduced bacterial loads by over 99.9% 
in only one application (68). Moreover, Stojiljkovic and colleagues demonstrated that the 
viability of human primary fibroblasts was unaffected when exposed to Ga-PPIX at 
concentrations up to 50-times the MIC of S. aureus (102). Combined, these results 
indicate that metalloporphyrins may be viable therapeutics. However, the mechanism of 
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their antibacterial activity is not yet understood. In order to develop metalloporphyrins for 
the clinic it is imperative that we understand their mode of action inside the cell. To this 
end I have shown that S. aureus grown anaerobically is more resistant to Ga-PPIX than 
aerobically respiring cultures (Figure 23A), indicating that Ga-PPIX may be poisoning a 
component of aerobic respiration. Considering the structural similarity to heme, we 
hypothesized that Ga-PPIX may be erroneously incorporated into heme-binding 
proteins, such as cytochromes. Exposure to Ga-PPIX increases lactate production in 
aerobically respiring cultures, indicating that Ga-PPIX induces S. aureus to switch to 
fermentative metabolism (Figure 23B). Combined, these data suggest that Ga-PPIX is 
incorporated into membrane-associated cytochromes in the place of heme. Unlike iron, 
which commonly exists in the +2 or +3 oxidation states, gallium has one valence state 
and only exists as Ga+3. Therefore, Ga-PPIX does not have the same oxidation potential 
as heme, which could inhibit cytochrome-mediated electron transport, resulting in the 
over-production of oxidative radicals and observed toxicity. However, S. aureus is not 
fully resistant to Ga-PPIX when grown anaerobically (Figure 23B), suggesting that the 
mechanism of Ga-PPIX toxicity is more complicated than simply blocking aerobic 
respiration through cytochrome inactivation. Further research is needed to investigate 
the mechanism of Ga-PPIX toxicity in bacteria.   
Herein I have defined the subcellular localization of the non-iron metalloporphyrin 
Ga-PPIX and demonstrated its value as a surrogate for heme trafficking. Additionally, I 
have demonstrated that exogenously acquired heme can be visualized by EM. 
Combined, these techniques are valuable tools to further elucidate the localization of 
exogenously acquired heme inside S. aureus. Considering the requirement for heme 
during staphylococcal pathogenesis, understanding the fate of intact heme may lead to 
the development of novel therapeutics.  
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CHAPTER VI 
 
CONCLUSIONS 
 
Summary 
 
Most bacterial pathogens require iron to be infectious and Staphylococcus 
aureus is no exception (74). However, the neutral pH found within a vertebrate host 
renders iron insoluble (8). Moreover, host iron-binding proteins such as hemoproteins, 
lactoferrin, transferrin, and ferritin are present in sufficient quantities to bind virtually all 
available iron (117). In order to acquire iron during infection bacteria must overcome 
these host sequestration techniques known as nutritional immunity (117). The majority 
(80%) of iron in the human body is found as a component of the tetrapyrrolic molecule 
heme (8). Heme is a cofactor in many proteins, the most abundant of which is the 
oxygen transport protein hemoglobin, found within circulating erythrocytes. S. aureus is 
capable of utilizing hemoglobin as an iron source, a process which is dependent upon 
expression of proteins of the iron-regulated surface determinant (Isd) system (108). It is 
modeled that upon erythrocyte lysis by staphylococcal hemolysins, hemoglobin is 
released at the site of infection. The S. aureus Isd machinery then binds hemoglobin, 
removes the heme cofactor, and traffics heme into the cytoplasm (98). In order to utilize 
heme as an iron source the porphyrin ring must be cleaved to release nutrient iron. To 
this end, the cytoplasmic proteins of the Isd system, IsdG and IsdI, catalytically degrade 
heme, releasing free iron (96).  
Although heme-iron acquisition is vital for staphylococcal pathogenesis (97, 108), 
the intracellular components of this process have not been examined. More specifically, 
the requirement for two heme-degrading enzymes has not been investigated and the 
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role of heme degradation in pathogenesis remains undefined. I have demonstrated that 
IsdG and IsdI are each required for S. aureus growth on heme as a sole iron source 
(Chapter II). The observation that both single heme oxygenase mutants are impaired for 
growth on heme indicates that IsdG and IsdI are not functionally redundant enzymes. In 
fact, I have established that IsdG and IsdI are differentially regulated depending upon 
the microenvironment encountered by the bacterium. In low iron environments Fur-
mediated repression is released and both isdG and isdI are transcribed. IsdG is 
additionally regulated post-transcriptionally by heme. Therefore, IsdI is most abundantly 
expressed in iron-deplete environments, while IsdG levels are maximal in low iron 
conditions containing heme. These observations provide insight into the basis for two 
paralogous enzymes in S. aureus with seemingly identical functions (Chapter II). We 
hypothesize that this differential regulation allows S. aureus to rapidly adapt to the 
microenvironment it encounters during infection.  
Accordingly, we have demonstrated that IsdG and IsdI are each required for full 
staphylococcal pathogenesis during systemic infection. While both isdG and isdI mutants 
are impaired for colonization of the hearts of infected animals, only the isdG mutant is 
defective at colonizing the kidneys. This organ-specific phenotype is not yet understood; 
however, we hypothesize that the variability in iron and heme concentrations in each 
organ may dictate the differential requirement for IsdG and IsdI during infection. The 
observed decrease in the virulence of staphylococcal strains lacking IsdG and IsdI 
suggests that these enzymes are expressed and functional during a wild type infection. 
To this end, I have utilized a luminescent transcriptional reporter system (IVIS) to 
demonstrate that isdI is expressed in vivo during staphylococcal pathogenesis (Chapter 
II). Moreover, the co-localization of luminescence with sites of abscess formation in the 
livers and kidneys of infected animals indicates that abscesses are iron-starved 
microenvironments. Although isdG and isdI mutants are not impaired at colonizing the 
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liver of infected animals, IVIS data indicate that the hepatic abscesses are iron-starved 
environments. The liver is the iron storage organ in vertebrates; therefore, we 
hypothesize that non-heme iron sources can be readily obtained, rendering heme 
oxygenase activity dispensable for colonization of the liver. According to the model 
proposed above, hepatic abscesses may be an example of an iron-deplete environment 
in which Fur-mediated transcriptional repression is released and isdG and isdI are 
transcribed. However due to the lack of heme, IsdG is not required and is therefore 
degraded. Notably, these experiments are the first to demonstrate a requirement for 
bacterial heme oxygenases in pathogenesis and establish the staphylococcal abscess 
as an iron-starved microenvironment. 
Our results reveal that IsdG and IsdI are required for staphylococcal 
pathogenesis and suggest that the differential regulation of these enzymes is important 
during infection. The regulated synthesis of proteins is widely accepted as a mechanism 
by which bacteria can adapt to their surroundings; however, targeted proteolysis is only 
beginning to be recognized as an equally important adaptive strategy (42). Although 
seemingly a drastic solution, the targeted destruction of proteins allows the bacterium to 
adapt rapidly to the changing environment (37). The mechanism by which 
staphylococcal proteases specifically recognize and degrade cellular proteins is not well 
understood.  
To more precisely define the role for heme oxygenase activity in vivo, we sought 
to elucidate the mechanism of IsdG degradation (Chapter III). I have demonstrated that 
ATP is required for IsdG degradation, indicating a role for ATP-dependent proteases in 
the regulation of IsdG. Moreover, the flexible loop region encompassing amino acids 82-
88 is required for IsdG degradation. These results suggest that the flexible loop may be 
recognized by cellular proteases that specifically degrade IsdG in the absence of heme. 
Alternatively, a distinct motif of IsdG may be recognized by proteolytic machinery, which 
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cleaves IsdG at the flexible loop. Further research is needed to determine how IsdG is 
targeted and degraded. Importantly, the high degree of structural and sequence 
similarity between IsdG and IsdI provides an amenable system for analysis of proteolytic 
substrate specificity in S. aureus.  
Heme oxygenases are ubiquitous enzymes in nature and are highly conserved 
from humans to plants and bacteria. All previously identified bacterial heme oxygenases 
are structurally similar to human heme oxygenase 1 (HO-1) (29, 120). Heme catabolism 
by the HO-1 family has been studied extensively in both bacteria and vertebrates and 
the mechanism of heme degradation proceeds similarly across all heme oxygenases, 
resulting in the production of α-biliverdin (110). IsdG and IsdI represent the founding 
members of the novel IsdG-family of heme oxygenases (81, 125). Due to the unique 
three-dimensional structure and mode of heme binding by IsdG-like enzymes, it has 
been hypothesized that this new family of heme oxygenases degrades heme by a 
distinct mechanism. Here, we demonstrate that IsdG and IsdI degrade heme to a 
mixture of β- and δ-oxo-bilirubin isomers, which we have collectively named 
staphylobilins (Chapter IV).  
Staphylobilin is a novel heme catabolite that has not been previously observed or 
characterized. Staphylobilin differs from the canonical heme degradation product 
biliverdin in several ways. First, the vast majority of HO-1-like exclusively cleave the 
tetrapyrrole ring at the α-meso carbon. The single exception in bacteria is PigA from 
Pseudomonas aeruginosa, which produces a mixture of biliverdin isomers (79). Unlike 
the HO-1 family, IsdG and IsdI cleave the porphyrin ring at the β- or δ-meso carbon, 
presumably dependent upon the orientation of molecular oxygen in the active site. 
Moreover, all HO-1-like enzymes produce biliverdin, which is then converted to bilirubin 
in mammals by biliverdin reductase. The IsdG-family degrades heme directly to a 
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bilirubin-like molecule with the addition of a carbonyl group at the β- or δ-bridge. 
Considering the important roles of biliverdin and bilirubin within vertebrate cells, it is 
likely that staphylobilins may have important functions within bacterial pathogens, such 
as S. aureus. This is particularly intriguing considering the varying production of β- and 
δ-isomers by IsdG and IsdI. It is possible that each isomer of staphylobilin is utilized 
under distinct environmental conditions, a requirement mediated by the differential 
regulation of IsdG and IsdI.  
In addition to its value as an iron source, heme is potentially valuable to S. 
aureus in its intact form. This is due to the requirement for heme as a cofactor in many 
bacterial proteins and the thermodynamic advantage of importing host heme, rather than 
synthesizing heme de novo. Accordingly, it has been established that exogenously 
acquired heme is preferentially acquired and segregated to the plasma membrane (97); 
however, the intracellular fate of intact heme is unknown. To this end I have established 
Ga-PPIX as a useful tool for tracking subcellular heme localization (Chapter V). Non-iron 
metalloporphyrins, including Ga-PPIX, are not degraded by the heme oxygenases IsdG 
and IsdI. Therefore, these molecules are viable surrogates for intact heme. Similarly to 
heme, Ga-PPIX is preferentially sorted to the staphylococcal membrane. Our current 
model predicts that Ga-PPIX exerts its antibacterial effect at the membrane by binding to 
cytochromes in place of heme and disrupting electron transport. Although anaerobically 
grown S. aureus is not entirely resistant to Ga-PPIX, indicating that the mechanism of 
toxicity may be more complex than simply inhibiting respiration. Further research is 
necessary to elucidate the mechanism of Ga-PPIX toxicity in this bacterium.  
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Future Directions 
 
Determine the impact of IsdG degradation on pathogenesis. 
 IsdG and IsdI are differentially regulated depending upon the microenvironment 
encountered by S. aureus. Accordingly, mutants lacking either isdG or isdI display 
distinct virulence defects, demonstrating that they are differentially required during 
pathogenesis. Specifically, the isdG-deficient strain exhibits a more pronounced defect in 
the hearts and kidneys of infected animals. Therefore, we hypothesize that the heme-
dependent stability of IsdG may be required for efficient staphylococcal pathogenesis.  
To test this hypothesis, the flexible loop sequence of IsdG will be mutated in the 
chromosome to that of the IsdI loop sequence (IsdGloop*). I have demonstrated that the 
flexible loop is required for IsdG degradation in the absence of heme (Chapter III). 
Therefore, it is expected that IsdG will be stable in this mutant, independently of heme. 
This mutation may render S. aureus less virulent, as it will not be able to fine-tune the 
abundance of IsdG in order to quickly adapt to its environment. Moreover, I have shown 
that non-degraded heme is preferentially sorted to the plasma membrane where it is 
likely incorporated into bacterial cytochromes (Chapter V). The IsdGloop* mutant will 
presumably have less non-degraded heme in the cytoplasm due to the over-abundance 
of heme oxygenase activity, and may therefore have altered cytochrome function. 
Alternatively, the IsdGloop* mutant may not exhibit a virulence defect. The vertebrate host 
is an iron-starved environment rich in heme and a mutation that renders S. aureus more 
efficient at heme degradation may give the bacterium a pathogenic advantage. However, 
this benefit would be expected to come at the cost of maximal growth in low-heme 
environments. Results from this experiment will provide further insight into the role of 
heme degradation in pathogenesis and the requirement for two heme oxygenases in S. 
aureus.  
 106 
Identify the minimum region necessary to target a protein for degradation.  
 The regulated degradation of intracellular proteins is a critical component of the 
bacterial life cycle. In order to remove damaged, misfolded, or unnecessary proteins the 
bacterium must have a means of identifying these potentially toxic proteins. Several 
recognition sequences are known in E. coli and these are assumed to be consistent in 
other bacteria; however, few have been tested in S. aureus. I have demonstrated that 
the flexible loop sequence is required for IsdG degradation but is not sufficient to target a 
protein for degradation. I hypothesize that the flexible loop is the site of proteolytic 
cleavage, but the recognition motif that targets IsdG for degradation is located at a 
distinct site on the protein.  
In order to identify the region of IsdG that is recognized for degradation, I have 
made a panel of chimeric proteins that contain regions of both IsdG and IsdI sequence 
(Figure 24). All chimeras have been expressed and purified from E. coli and the heme 
binding and degradation were found to be similar to wild type IsdG and IsdI. Pulse-chase 
analyses will be performed and the chimera(s) with heme-dependent stability will be 
identified. It is expected that chimeras containing the flexible loop sequence of IsdG will 
exhibit heme-dependent stability if they also contain the recognition motif. From these 
experiments we will be able to further define the mechanism by which IsdG is targeted 
for degradation and may be able to utilize the recognition motif to identify other protease 
substrates. 
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Figure 24. IsdG and IsdI chimeras. A. Schematic of IsdG, IsdI, and chimeric proteins. 
Secondary structural elements are indicated. B. Three-dimensional crystal structures of 
IsdG bound to heme (black), color-coded to indicate the portions of each chimera 
corresponding to IsdG (yellow) or IsdI (blue) sequence. 
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Identify the protease(s) responsible for IsdG degradation.  
 
IsdG degradation is ATP- and heme-dependent, suggesting that under specific 
conditions IsdG is targeted for degradation by an ATP-dependent intracellular protease 
(Chapter IIII). To date, the majority of work on bacterial intracellular proteases has 
focused on the model Gram negative bacterium E. coli, which expresses four classes of 
cytoplasmic proteases: serine proteases ClpP, HslV and Lon, and the metalloprotease 
FtsH (36). Of these, S. aureus expresses proteins with homology to ClpP, HslV, and 
FtsH; no staphylococcal Lon homologue has been identified (Table 4) (31, 32, 55).  
The Clp (caseinolytic protease) family of serine proteases is ubiquitous in 
bacteria and is the best characterized intracellular protease family. ClpP and HslV (also 
named ClpQ) are peptidase subunits that associate with ATPase subunits to form holo-
proteolytic complexes. Staphylococcal ClpP can associate with ClpC or ClpX while HslV 
only complexes with HslU (30, 32). It is not yet known if the Clp ATPases ClpB and ClpL 
can interact with ClpP (30). Although Clp ATPases are ubiquitous in bacteria, the 
number and type vary, suggesting some degree of functional redundancy. S. aureus 
mutants lacking clpP or an ATPase component exhibit defects in stress tolerance, 
biofilm formation, and defective regulation of virulence factors (30, 31). Conversely, a S. 
aureus hslUV mutant is only impaired for growth at very high temperatures, but is fully 
capable of adapting to other stressors (32). The mechanism by which these serine 
proteases mediate these effects is not well understood.  
FtsH (named for its filamentous temperature-sensitive phenotype in E. coli) is a 
membrane-bound ATP- and Zn2+-dependent metalloprotease that contains both an 
ATPase domain and a proteolytic domain. FtsH is known to degrade both cytoplasmic 
and integral membrane proteins (43). A S. aureus ftsH mutant exhibits reduced viability 
under starvation conditions, slower growth, and increased sensitivity to multiple 
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stressors (55). However, no staphylococcal FtsH substrates have been identified and the 
biochemical properties of this protease have not been examined.  
 In order to identify the protease(s) responsible for IsdG degradation I have 
constructed deletion strains of hslUV and ftsH. The clpP deletion strain in the Newman 
background was a gift from Hanne Ingmer at the University of Copenhagen (Table 4). I 
plan to test the stability of IsdG in each of these protease-deficient strains by pulse-
chase analysis. ATPase subunits recognize, unfold, and translocate substrates into the 
active site of the proteolytic subunit. If the clpP mutant is unable to degrade IsdG 
similarly to wild type, I plan to test IsdG stability in strains lacking individual ATPases to 
determine which ATPase subunit is involved in recognizing IsdG. To this end, I am 
currently generating deletion strains of clpB, clpC, clpL, and clpX (Table 4). As ClpB and 
ClpL are functionally redundant, I also plan to generate strains lacking a combination of 
ATPases (30). These strains will be valuable for elucidating the mechanism of IsdG 
degradation in the absence of heme. Additionally, these strains will advance our 
understanding of regulated proteolysis in S. aureus. To date, studies on staphylococcal 
intracellular proteases have focused only on stress-induced pleiotropic effects and the 
regulation of a subset of virulence factors (30, 32, 55). These protease- and ATPase-
deficient strains can be utilized for proteomic and transcriptional analyses to elucidate 
the molecular mechanism of protease regulation, substrate recognition, and degradation.  
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Table 4. ATP-dependent intracellular proteases in S. aureus 
 
Gene Name Function Deletion strain 
NWMN_0473 ftsH ATP- and Zn
2+-dependent 
metalloprotease  confirmed 
NWMN_0487 clpC ATP-binding subunit, associates with ClpP in process 
NWMN_0736 clpP Proteolytic subunit, associates with ClpC and ClpX received (31) 
NWMN_0845 clpB ATP-binding subunit in process 
NWMN_1163 hslV Proteolytic subunit, associates with HslU confirmed 
NWMN_1164 hslU ATP-binding subunit, associates with HslV confirmed 
NWMN_1568 clpX ATP-binding subunit, associates with ClpP in process 
NWMN_2448 clpL ATP-binding subunit in process 
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According to our model, heme binds IsdG, altering its conformation such that it is 
no longer recognized as a substrate for proteolysis. However, it is also possible that 
exogenously acquired heme induces a general stress response in the cell which recruits 
cellular proteases to other substrates, resulting in increased IsdG stability (129). In this 
scenario, the recognition sequence that targets IsdG for degradation is unchanged but 
the cellular environment is altered, rendering IsdG more stable. Exhaustive attempts at 
creating IsdG point mutants that are incapable of binding heme have been unsuccessful. 
Therefore, I cannot directly test the effect of exogenous heme on IsdG stability when 
IsdG is not able to bind heme. To test the possibility that IsdG stabilization is a side-
effect of heme toxicity, I plan to analyze the effect of the non-toxic heme analogue Co-
PPIX on IsdG stability. This metalloporphyrin binds IsdG but does not induce toxicity, 
enabling us to separate the conformational change induced by porphyrin binding and the 
potential cellular stress caused by heme. Results from these experiments will further 
elucidate the mechanism of heme-dependent IsdG stability.  
 
Determine the fate and function of staphylobilin 
The products of mammalian heme degradation, iron, biliverdin, and carbon 
monoxide, have many important functions, some of which include immunomodulation 
and cytoprotection (47). Additionally, biliverdin is converted to bilirubin, the most potent 
antioxidant in the plasma (101). However no homologue of biliverdin reductase has been 
found in bacteria and the function of biliverdin in the cell is unknown. Although the 
mechanism of the IsdG-family of enzymes is not yet known, the reaction is thought to 
require nine electrons, two electrons more than canonical heme degradation that 
produces biliverdin. The extra energy required to produce staphylobilin indicates that it 
may have important functions in the cell. Unlike bilirubin, however, staphylobilin is not 
expected to have antioxidant properties due to the substitution of a carbonyl in place of 
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the hydrogen at the γ-bridge of bilirubin. Thus, the function of staphylobilin inside S. 
aureus is unknown. 
In addition to the function of biliverdin and staphylobilin, there are many other 
aspects of bacterial heme degradation that are not well understood. In vitro experiments 
indicate that an additional factor is necessary in vivo to remove biliverdin or staphylobilin 
from the heme oxygenase active site. However, the identity and function of this 
hypothetical factor have not been uncovered. Moreover, unlike other bacterial heme 
oxygenases, recombinant IsdG and IsdI are purified from E. coli as apo-proteins. There 
are several possible reasons for this discrepancy: (i) the IsdG-family requires heme to be 
delivered to the heme oxygenase and the factor(s) that perform this task in vivo are not 
expressed in E. coli; (ii) the IsdG-family of heme oxygenases requires a different 
reducing environment to effectively bind heme than is found in the E. coli cytoplasm; (iii) 
the IsdG-family is capable of degrading heme in E. coli and the staphylobilin that is 
bound to the purified protein has not been detected. To answer these questions we plan 
to perform a bacterial-two-hybrid experiment to screen for proteins in the cell that 
interact with IsdG and/or IsdI. This experiment may identify proteins involved in 
transporting heme to the heme oxygenase, similarly to PhuS in Pseudomonas 
aeruginosa, which delivers heme to the heme oxygenase PigA (52). It may also identify 
factors involved in trafficking staphylobilin away from IsdG or IsdI. It is also possible that 
the bacterial-two-hybrid system will identify protease components or chaperone proteins 
that recognize IsdG in the absence of heme. 
An alternative approach is to directly select for proteins that bind staphylobilin in 
the cell. To this end I plan to add 14C-heme to S. aureus pisdG (isdG over-expression) or 
ΔisdGI and separate proteins of the cell wall, membrane, and cytoplasmic fractions by 
electrophoresis. Radiolabeled proteins will be visualized using a phosphorimager and 
can be identified by tryptic digest and mass spectrometry of identical non-radiolabeled 
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samples. By comparing the bands found in samples from S. aureus pisdG but not in 
ΔisdGI, we may be able to identify proteins specifically bound to staphylobilin rather than 
intact heme. Further, I plan to purify staphylobilin in large quantities and add it to S. 
aureus ΔisdGI grown in various stress-inducing conditions to identify an environment in 
which staphylobilin production may benefit the cell. Results from these experiments have 
the potential to identify proteins that bind staphylobilin and discover growth conditions 
under which S. aureus requires staphylobilin. Combined, these studies will begin to 
elucidate the function of staphylobilin in the cell.   
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